Health effects of electronic cigarettes

Nicotine electronic cigarettes (“e-cigs” or “vapes”) can damage people's health, especially children's, but are far less harmful than smoking. Electronic cigarettes increase the risk of asthma and chronic obstructive pulmonary disease (COPD) compared to not using nicotine at all. Pregnant women vaping may increase the risk of their children suffering from asthma and COPD. Vaping is associated with heart failure, and can cause seizures. Unregulated or modified e-cigs or liquids may be more dangerous than those whose production is well-regulated. Misuse, accidents, and product malfunction issues increase risks such as nicotine poisoning, contact with liquid nicotine, and severe burns.

Some of the most common but less serious adverse effects include abdominal pain, headache, blurry vision, throat and mouth irritation, vomiting, nausea, and coughing. People can become dependant on vapes. Nicotine is addictive and harmful to fetuses, children, and young people. However vaping while pregnant is less dangerous than smoking while pregnant. Passive e-cigarette vapor exposure may be harmful to children, but more studies are needed as of 2026.

Adverse effects of vaping

Randomized controlled trials have provided "high-certainty" evidence that e-cigarettes containing nicotine are more effective than nicotine replacement therapy for discontinuing tobacco smoking, and moderate‐certainty evidence that they are more effective than e-cigarettes free of nicotine.

Harm reduction

Switching from tobacco to vaping may reduce weight gain after smoking cessation, increase exercise tolerance, reduce exposure to toxic chemicals, and reduce risk of death. Vaping may reduce shortness of breath, reduce coughing, reduce spitting, and reduce sore throat compared to tobacco.
Effects of vaping, compared to tobacco smoking

When a person does not want to quit nicotine, harm reduction means striving to eliminate exposure to smoke by replacing it with vaping. E-cigarettes can reduce smokers' exposure to carcinogens and other toxic chemicals found in tobacco.

Tobacco harm reduction has been a controversial area of tobacco control. Health advocates have been slow to support a harm reduction method out of concern that tobacco companies cannot be trusted to sell products that will lower the risks associated with tobacco use. A large number of smokers want to reduce harm from smoking by instead using e-cigarettes. Quitting smoking is the most effective strategy for tobacco harm reduction.

Tobacco smoke contains 100 known carcinogens and 900 potentially cancer-causing chemicals, but e-cigarette vapor contains fewer potential carcinogens than tobacco smoke. A 2025 review of 39 studies found "no significant incident or prevalent risk" of cancer from vaping. Due to their similarity to traditional cigarettes, e-cigarettes could play a valuable role in tobacco harm reduction. The public health community remains divided concerning the appropriateness of endorsing a device whose safety and efficacy for smoking cessation remain unclear.[better source needed] Overall, the available evidence supports the cautionary implementation of harm reduction interventions aimed at promoting e-cigarettes as attractive and competitive alternatives to cigarette smoking, while taking measures to protect vulnerable groups and individuals. An evidence review commissioned by England's Office for Health Improvement and Disparities (OHID) concluded that, in the short and medium term, vaping poses a small fraction of the risks of smoking, while noting that vaping is not risk-free for people who have never smoked.

Evidence to substantiate the potential of vaping to lower tobacco-related death and disease is unknown. E-cigarettes could have an influential role in tobacco harm reduction. One study's authors warned against the potential harm of excessive regulation and advised health professionals to consider advising smokers who are reluctant to quit by other methods to switch to e-cigarettes as a safer alternative to smoking.

Smoking cessation

E-cigarettes can help people quit smoking, but only about one in ten quit. Limited evidence suggests that e-cigarettes likely do help people to stop smoking when used in clinical settings. However, more smokers become dual users than succeed in complete abstinence. Outside clinical settings, vaping does not greatly change the odds of quitting smoking.

The public health community is divided over the use of these devices to reduce or prevent smoking. As of 2017, they were not approved by the US Centers for Disease Control and Prevention (CDC) as a smoking cessation product, and in 2020, they became regulated as a tobacco product, despite not containing tobacco. However, a 2019 study reported that 10% of participants given nicotine via gum, mouth spray, patches, etc., quit smoking, while 18% of those given vaping kits quit. Among study participants still smoking, e-cigarette users smoked less. A 2021 review by Public Health England (PHE) reported vaping to be around 95% less harmful than smoking. E-cigarettes are estimated to have preserved 677,000 life–years in the US alone from 2011 to 2019.

A small number of studies have looked at whether using e-cigarettes reduces the number of cigarettes smokers consume. It is unclear whether e-cigarettes are only helpful for particular types of smokers. Vaping with nicotine may reduce tobacco use among daily smokers. Whether vaping is effective for quitting smoking may depend on whether it was used as part of an effort to quit.

Evidence suggests smokers are more frequently able to completely quit smoking using tank devices compared to cigalikes, which may be due to their more efficient nicotine delivery. One study supports the claim that smokers are more likely to use e-cigarettes as a nicotine replacement product to aid in smoking cessation than other pharmaceutical products.

There is low-quality evidence that vaping assists smokers to quit smoking in the long-term compared with nicotine-free vaping. Tentative evidence indicates that health warnings on vaping products may influence users to give up vaping.

There is robust evidence that vaping is not effective for quitting smoking among adolescents. In view of the shortage of evidence, vaping is not recommend for cancer patients, although for all patients vaping is likely less dangerous than smoking cigarettes. The effectiveness of vaping for quitting smoking among vulnerable groups is uncertain.

Safety

Ecigs are harmful to children, but there is no consensus on the risks of e-cigarette use by adults. There is little data about their safety, and a considerable variety of liquids are used as carriers, and thus are present in the aerosol delivered to the user. One 2025 study found no serious respiratory effects, whereas another found that vaping is associated with chronic obstructive pulmonary disease but less so than smoking. Regulated US FDA products such as nicotine inhalers may be safer than e-cigarettes, but e-cigarettes are safer than combusted tobacco products such as cigarettes.

The risk of early death is anticipated to be similar to that of smokeless tobacco.[need quotation to verify] Since vapor does not contain tobacco and does not involve combustion, users may avoid several harmful constituents usually found in tobacco smoke, such as ash, tar, and carbon monoxide. However, e-cigarette use with or without nicotine cannot be considered risk-free because the long-term effects of e-cigarette use are unknown. There is "only limited evidence showing adverse respiratory and cardiovascular effects in humans", with the authors of a 2020 review calling for more long-term studies on the subject.

Possible side effects of nicotine include increased clotting tendency, atherosclerosis, enlargement of the aorta, bronchospasm, muscular tremor and pain, gastrointestinal nausea, dry mouth, dyspepsia, diarrhea, heartburn, peptic ulcer, cancer, lightheadedness, headache, sleep disturbances, abnormal dreams, irritability, dizziness, blood restriction, increased or decreased heart rate, increased blood pressure, tachycardia, more (or less) arrhythmias, coronary artery constriction, coronary artery disease, high insulin, insulin resistance, and risks to the child later in life during pregnancy include type 2 diabetes, obesity, hypertension, neurobehavioral defects, respiratory dysfunction, and infertility.
Possible side effects of nicotine

The cytotoxicity of e-liquids varies, and contamination with various chemicals have been detected in the liquid. Metal parts of e-cigarettes in contact with the e-liquid can contaminate it with metal particles.

Nicotine is associated with cardiovascular disease and poisoning, and possibly with birth defects. As of 2025, there is insufficient evidence of cancer caused directly by e-cigarettes.

In 2021, researchers at Johns Hopkins University reported over 2,000 unknown chemicals in the vape clouds that they tested from Vuse, Juul, Blu and Mi-Salt vape devices.

E-cigarettes create vapor that consists of fine and ultrafine particles of particulate matter, with the majority of particles in the ultrafine range. The vapor have been found to contain propylene glycol, glycerin, nicotine, flavors, small amounts of toxicants, and heavy metals, as well as metal nanoparticles, and other substances. Exactly what the vapor consists of varies in composition and concentration across and within manufacturers, and depends on the contents of the liquid, the physical and electrical design of the device, and user behavior, among other factors.

The majority of toxic chemicals found in cigarette smoke are absent in e-cigarette vapor. E-cigarette vapor contains lower concentrations of potentially toxic chemicals than with cigarette smoke. Those which are present, are mostly below 1% of the corresponding levels permissible by workplace safety standards. But workplace safety standards do not recognize exposure to certain vulnerable groups such as people with medical ailments, children, and infants who may be exposed to second-hand vapor.

Addiction

Nicotine, a key ingredient in most e-liquids, is well-recognized as one of the most addictive substances, as addictive as heroin and cocaine. Addiction is believed to be a disorder of experience-dependent brain plasticity. The reinforcing effects of nicotine play a significant role in the beginning and continuing use of the drug. First-time nicotine users develop a dependence about 32% of the time. Chronic nicotine use involves both psychological and physical dependence. Nicotine-containing e-cigarette vapor induces addiction-related neurochemical, physiological and behavioral changes. Nicotine affects neurological, neuromuscular, cardiovascular, respiratory, immunological and gastrointestinal systems.

Neuroplasticity within the brain's reward system occurs as a result of long-term nicotine use, leading to nicotine dependence. The neurophysiological activities that are the basis of nicotine dependence are intricate. It includes genetic components, age, gender, and the environment. Nicotine addiction is a disorder which alters different neural systems such as dopaminergic, glutamatergic, GABAergic, serotoninergic, that take part in reacting to nicotine. Long-term nicotine use affects a broad range of genes associated with neurotransmission, signal transduction, and synaptic architecture. The ability to quit smoking is affected by genetic factors, including genetically based differences in the way nicotine is metabolized.

An image of the human brain. The reinforcing effects of addictive drugs, such as nicotine, are associated with their ability to excite the mesolimbic and dopaminergic systems. How does the nicotine in e-cigarettes affect the brain? Until about age 25, the brain is still growing. Each time a new memory is created or a new skill is learned, stronger connections – or synapses – are built between brain cells. Young people's brains build synapses faster than adult brains. Because addiction is a form of learning, adolescents can get addicted more easily than adults. The nicotine in e-cigarettes and other tobacco products can also prime the adolescent brain for addiction to other drugs such as cocaine.
The reinforcing effects of addictive drugs, such as nicotine, are associated with its ability to excite the mesolimbic and dopaminergic systems.
How does the nicotine in e-cigarettes affect the brain? Until about age 25, the brain is still growing. Each time a new memory is created or a new skill is learned, stronger connections – or synapses – are built between brain cells. Young people's brains build synapses faster than adult brains. Because addiction is a form of learning, adolescents can get addicted more easily than adults.

Nicotine is a parasympathomimetic stimulant that binds to and activates nicotinic acetylcholine receptors in the brain, which subsequently causes the release of dopamine and other neurotransmitters, such as norepinephrine, acetylcholine, serotonin, gamma-aminobutyric acid, glutamate, endorphins, and several neuropeptides, including proopiomelanocortin-derived α-MSH and adrenocorticotropic hormone. Corticotropin-releasing factor, Neuropeptide Y, orexins, and norepinephrine are involved in nicotine addiction. Continuous exposure to nicotine can cause an increase in the number of nicotinic receptors, which is believed to be a result of receptor desensitization and subsequent receptor upregulation.

Long-term exposure to nicotine can also result in downregulation of glutamate transporter 1. Long-term nicotine exposure upregulates cortical nicotinic receptors, but it also lowers the activity of the nicotinic receptors in the cortical vasodilation region. These effects are not easily understood. With constant use of nicotine, tolerance occurs at least partially as a result of the development of new nicotinic acetylcholine receptors in the brain.

After several months of nicotine abstinence, the number of receptors go back to normal. The extent to which alterations in the brain caused by nicotine use are reversible is not fully understood. Nicotine also stimulates nicotinic acetylcholine receptors in the adrenal medulla, resulting in increased levels of epinephrine and beta-endorphin.

When nicotine intake stops, the upregulated nicotinic acetylcholine receptors induce withdrawal symptoms. These symptoms can include cravings for nicotine, anger, irritability, anxiety, depression, impatience, trouble sleeping, restlessness, hunger, weight gain, and difficulty concentrating. When trying to quit smoking with vaping a base containing nicotine, symptoms of withdrawal can include irritability, restlessness, poor concentration, anxiety, depression, and hunger. The changes in the brain cause a nicotine user to feel abnormal when not using nicotine. In order to feel normal, the user has to keep his or her body supplied with nicotine. E-cigarettes may reduce cigarette craving and withdrawal symptoms.

The addiction potential of e-cigarettes may have risen because as they have progressed, they have delivered nicotine better.

The National Institute on Drug Abuse said e-cigarettes could maintain nicotine addiction in those who are attempting to quit. The limited available data suggests that the likelihood of excessive use of e-cigarettes is smaller than traditional cigarettes. No long-term studies have been done on the effectiveness of e-cigarettes in treating tobacco addiction, but some evidence suggests that dual use of e-cigarettes and traditional cigarettes may be associated with greater nicotine dependence.

Adolescents are likely to underestimate nicotine's addictiveness. Vulnerability to the brain-modifying effects of nicotine, along with youthful experimentation with e-cigarettes, could lead to a lifelong addiction. A long-term nicotine addiction from using a vape may result in using other tobacco products. The majority of addiction to nicotine starts during youth and young adulthood. Adolescents are more likely to become nicotine dependent than adults.

The adolescent brain seems to be particularly sensitive to neuroplasticity as a result of nicotine. Minimal exposure could be enough to produce neuroplastic alterations in the very sensitive adolescent brain. A 2014 review found that in studies up to a third of young people who have not tried a traditional cigarette have used e-cigarettes. The degree to which teens are using e-cigarettes in ways the manufacturers did not intend, such as increasing the nicotine delivery, is unknown, as is the extent to which e-cigarette use may lead to addiction or substance dependence in young people.

In 2025 Alder Hey Children's Hospital set up the first NHS clinic for vape addiction in children. In the United States, the 2024 National Youth Tobacco Survey found that current e-cigarette use among middle and high school students declined from 2.13 million students, or 7.7%, in 2023 to 1.63 million students, or 5.9%, in 2024, about one-third of the number reported at the 2019 peak.

Positions

Medical organizations differ in their views about the health implications of vaping. There is general agreement that e-cigarettes expose users to fewer toxicants than tobacco cigarettes. Some healthcare groups and policy makers have hesitated to recommend e-cigarettes for quitting smoking, because of limited evidence of effectiveness and safety. Some have advocated bans on e-cigarette sales and others have suggested that e-cigarettes may be regulated as tobacco products but with less nicotine content or be regulated as a medicinal product.

A 2019 World Health Organization (WHO) report found that the scientific evidence is insufficient to support vaping as a smoking cessation tool. Healthcare organizations in the UK (including the Royal College of Physicians and Public Health England) have encouraged smokers to switch to e-cigarettes or other nicotine replacements if they cannot quit, as this would potentially save millions of lives.

In 2016, the US Food and Drug Administration (US FDA) stated that "Although ENDS [electronic nicotine delivery systems] may potentially provide cessation benefits to individual smokers, no ENDS have been approved as effective cessation aids." In 2019 the European Respiratory Society stated that "[t]he tobacco harm reduction strategy is based on well-meaning but incorrect or undocumented claims or assumptions."

The scientific community in the United States and Europe are primarily concerned with the possible effect of electronic cigarette use on public health. There is concern among public health experts that e-cigarettes could renormalize smoking, weaken measures to control tobacco, and serve as a gateway for smoking among youth. The public health community is divided over whether to support e-cigarettes, because their safety and efficacy for quitting smoking is unclear. Many in the public health community acknowledge the potential for their quitting smoking and decreasing harm benefits, but there remains a concern over their long-term safety and potential for a new era of users to get addicted to nicotine and then tobacco. There is concern among tobacco control academics and advocates that prevalent universal vaping "will bring its own distinct but as yet unknown health risks in the same way tobacco smoking did, as a result of chronic exposure", among other things.

Medical organizations avoid releasing statements about the relative toxicity of electronic cigarettes because of the many different device types, liquid formulations, and new devices that come onto the market. Some healthcare groups and policy makers have hesitated to recommend e-cigarettes with nicotine for quitting smoking, despite some evidence of effectiveness (when compared to Nicotine Replacement Therapy or e-cigarettes without nicotine) and safety. Reasons for hesitancy include challenges ensuring that quality control measures on the devices and liquids are met, unknown second hand vapour inhalation effects, uncertainty about EC use leading to the initiation of smoking or effects on people new to smoking who develop nicotine dependence, unknown long-term effects of electronic cigarette use on human health, uncertainty about the effects of ECs on smoking regulations and smoke free legislation measures, and uncertainty about involvement of the tobacco industry.

Some have advocated bans on e-cigarette sales and others have suggested that e-cigarettes may be regulated as tobacco products but with less nicotine content or be regulated as a medicinal product. A 2016 World Health Organization (WHO) report found that the scientific evidence for the effectiveness of vaping for quitting smoking is "scant and of low certainty". In 2016, the US Food and Drug Administration (FDA) stated that "Although ENDS [electronic nicotine delivery systems] may potentially provide cessation benefits to individual smokers, no ENDS have been approved as effective cessation aids." In 2019 the European Respiratory Society stated that "The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term." Following hundreds of possible cases of severe lung illness and five confirmed deaths associated with vaping in the US, the Centers for Disease Control and Prevention stated on September 6, 2019, that people should consider not using vaping products while their investigation is ongoing.

International

In August 2016, a report produced by the World Health Organization (WHO) for the Conference of the Parties to the WHO Framework Convention on Tobacco Control, found "there is not enough research to quantify the relative risk of ENDS/ENNDS over combustible products. Therefore, no specific figure about how much 'safer' the use of these products is compared to smoking can be given any scientific credibility at this time."

In May 2018, the Forum of International Respiratory Societies released a position statement, stating "ENDS are devices that deliver aerosols of nicotine and other volatile chemicals to the lung. Their use has rapidly escalated among youths and they are now the most commonly used tobacco product among adolescents. Initiation of electronic cigarette use is strongly associated with the subsequent initiation of combustible tobacco product use among adolescents."

Australia

In 2020 the Royal Australian College of General Practitioners updated their advice on smoking cessation, stating that "for people who have tried to achieve smoking cessation with approved pharmacotherapies but failed, but who are still motivated to quit smoking and have brought up e-cigarette usage with their healthcare practitioner, nicotine-containing e-cigarettes may be a reasonable intervention to recommend."

Canada

Health Canada states in relation to the Tobacco and Vaping Products Act which became law on May 23, 2018, that "vaping is less harmful than smoking. Many of the toxic and cancer-causing chemicals in tobacco and the tobacco smoke form when tobacco is burned." They further state that "vaping products and e-cigarettes deliver nicotine in a less harmful way than smoking, and may reduce health risks for smokers".

The Canadian Heart and Stroke Foundation has stated, "While early studies show some potential benefits, the effectiveness of e-cigarettes with nicotine as a smoking cessation device is not fully conclusive," and expressed concerns about the lack of long-term studies with regard to health effects to the user as well as second-hand exposure. They also note public health officials' concerns about renormalizing smoking behavior undermining current tobacco control as well as being a gateway for nicotine addiction and tobacco use disorder.

China

About 1 adult in 4 smokes, but fewer than 1 in 100 vape. Tobacco-flavor is the only flavor allowed and ecigs cannot be sold online. In 2023 more middle school students smoked than vaped, and as of 2025 more university students - ecigs are not approved for stopping smoking. Over 1 in 5 deaths in China are due to smoking.

New Zealand

In 2020, the Ministry of Health of New Zealand issued a new position statement on nicotine vaping: "The Ministry considers vaping products could disrupt inequities and contribute to Smokefree 2025. The evidence on vaping products indicates they carry much less risk than smoking cigarettes but are not risk free. Evidence is growing that vaping can help people to quit smoking. There is no international evidence that vaping products are undermining the long-term decline in cigarette smoking among adults and youth, and may in fact be contributing to it." Position statement on vaping

The 2024 ASH Year 10 Snapshot Survey in New Zealand reported that regular vaping among 14- and 15-year-olds had fallen for a third consecutive year, to 14.1% in 2024 from a 2021 peak of 20.2%, while daily vaping fell to 8.7%.

Europe

However, in 2020 the World Health Organization Regional Office for Europe issued a report stating, "There is conclusive evidence that: Completely substituting electronic nicotine and non-nicotine delivery systems for combustible tobacco cigarettes reduces users' exposure to numerous toxicants and carcinogens present in combustible tobacco cigarettes."

France

In 2022, French health body le Haut Conseil de la santé publique (HCSP) said that health professionals should not recommend e-cigarettes for quitting, as there was not enough information on risks and benefits. Smokers trying to quit in France should not be offered vapes to help

United Kingdom

A 2022 Public Health England report reiterated the approximation that e-cigarettes are at least 95% less harmful than smoking.

United States

Government agencies

Following five confirmed deaths in the US, on September 6, 2019, the Centers for Disease Control and Prevention stated that while this investigation is ongoing, people should consider not using e-cigarette products. In 2016, the US Food and Drug Administration (FDA) stated that "Although ENDS [electronic nicotine delivery systems] may potentially provide cessation benefits to individual smokers, no ENDS have been approved as effective cessation aids." They also stated that "Although ENDS likely do not deliver the same level of toxicants as cigarettes, studies show that there are dangers associated with ENDS use". In July 2025, the FDA authorized Juul Labs’ tobacco- and menthol-flavored e-cigarette device and refill cartridges to remain on the U.S. market under the agency’s tobacco product authorization process, saying the evidence submitted showed potential benefits for adult smokers who switch completely to vaping, while reiterating that people who do not smoke should not use e-cigarettes.

Medical societies

On September 9, 2019, following an upsurge of reports of lung disease associated with vaping, the American Medical Association issued a statement saying "In light of increasing reports of e-cigarette-associated lung illnesses across the country, the AMA urges the public to avoid the use of e-cigarette products until health officials further investigate and understand the cause of these illnesses." The next day the American Lung Association issued a warning, saying "E-cigarettes are not safe and can cause irreversible lung damage and lung disease. No one should use e-cigarettes or any other tobacco product. This message is even more urgent today following the increasing reports of vaping-related illnesses and deaths nationwide." In 2019, the American Medical Association urged a complete ban on all types of vaping products that are not approved by the US FDA as quitting smoking aids.

Risk context

When evaluating the health effects of some activity, a reasonable question is "what is the practical alternative?" If the alternatives are worse, then the activity must be measured against the alternatives. If the alternative is smoking, the answer might be different than if the alternative is simply to avoid nicotine. This is because the health impacts of smoking are strongly negative, while the impacts of avoiding nicotine entirely are positive.

Smoking

E-cigarette vapor does not contain tobacco and does not involve combustion, therefore users do not encounter several harmful constituents of tobacco smoke, such as ash, tar, and carbon monoxide.

The NHS stated that smoking creates many harmful toxins linked to cancer, lung disease, heart disease and stroke, while vaping gives users nicotine by heating an e-liquid and exposes users to fewer toxins at lower levels than smoking cigarettes.

Smokers can use e-cigarettes for various purposes. As an aid to quitting smoking, vaping is a temporary activity that reduces smoking and terminates once the smoker has completed the transition away from nicotine. To the extent that vaping aids the transition, its health effects are positive.

Alternatively, smokers can substitute vaping for smoking without intending to transition. In this context, vaping is still preferred. However, if vaping is used as a way to get nicotine in situations where smoking is not convenient, vaping may negatively affect health.

Other smoker-transition aids are available and may offer better safety and/or effectiveness[citation needed] profiles then vaping. Given equal effectiveness, relatively safety considerations would become paramount. However, a large-scale 2025 analysis indicated that other smoking cessation products are less effective at aiding transition than vaping.

The Centers for Disease Control and Prevention states that cigarette smoking is the leading preventable cause of disease, death, and disability in the United States and is responsible for more than 480,000 deaths each year.

The WHO reported in 2025 that tobacco kills more than 7 million smokers each year and an estimated 1.6 million non-smokers exposed to second-hand smoke.

Individual effects

Health effects for non-smokers must be considered in absolute terms for long-term use as well as the risk of transition into traditional cigarettes, while for smokers the relative risks are paramount, and if used as a quitting aid, any short-term effects are most important.

Non-smokers

E-cigarettes create nicotine dependence in non-smokers. E-cigarettes may act as a gateway drug to smoking, particularly among youth. Pregnant or nursing women and the elderly are more sensitive to nicotine than other individuals.

Smokers

Used to transition to abstinence, e-cigarettes end the consumption of nicotine and the other harmful substances in tobacco smoke and later any harmful e-liquid ingredient. However, if abstinence is not achieved, e-cigarettes could mean increased nicotine dependence (by adding vaping to smoking) and ongoing harm from other e-liquid ingredients.

Health benefits associated with transitioning from smoking to vaping include decreased post-smoking weight gain and improved exercise tolerance.

Even a partially successful transition may allow smokers to reduce their cigarette consumption with related health benefits. A 2022 Cochrane review concluded that vaping increased quit rates compared to e-cigarettes without nicotine and compared to nicotine replacement therapy, although it did not compare vaping to other methods.[needs update]

A 2025 RCP review reported that e-cigarettes sold in England (which allow nicotine strength of no more than 20 mg/ml) are unlikely to exceed 5% of the harm of cigarettes for non-pregnant adults. This claim is consistent with the 2018 view of the US National Academies of Sciences, Engineering, and Medicine.

General

Device defects can result in e.g., battery explosions and may cause burns or other injuries. Concentrated e-liquid exposure can come by leaks or spills. Nicotine poisoning can occur by ingestion, inhalation, or absorption via the skin or eyes. A 2018 review concluded that exposure to second-hand vapor can reduce lung function.

Neurological

Many effects on the nervous and the sensory systems are possibly related to nicotine overdose or withdrawal. E-cigarettes can cause seizures.

Injuries

E-cigarettes typically use lithium batteries, which may cause injury if defective or misused. A 2016 study reported that the explosion risk was low.

Another 2016 study assembled reports of 92 explosion, fire, or overheating events, with related injuries in 47 individuals. Prominent harms included 2 cervical vertebral fractures, 1 palate fracture, 3 instances of damaged teeth, 33 thermal burns, 4 chemical burns, and 5 lacerations. A 2017 study reported that most e-cigarette fires are triggered by batteries overheating and igniting.: Summary, Conclusion 14-1., 9  In 2018 PHE reported six UK case studies involving e-cigarettes with burns.: 144 

An e-cigarette explosion or fire can induce serious burns and harms.: 149  Explosions have resulted in lost teeth, neck fractures, and burns from combustion and/or battery acid. Reported burns covered from 1% to 8% of body area. They were most commonly reported in the lower extremity, hands, head and neck, and genitalia. Explosions in some cases produced 2nd and 3rd degree burns. A 2018 review concluded that some 50% needed surgical management.

A 2017 review observed that several reported injury cases occurred while the e-cigarette was carried in a pocket. The pocket may have sufficient moisture to start a chemical reaction within the lithium-ion battery, while the presence of metal objects can create a short-circuit, leading to an explosion. Burn risk extends to bystanders.

Graphic from a July 2016 United States Fire Administration (USFA) report entitled Electronic Cigarette Fires and Explosions in the United States 2009 – 2016. There has been an increase in the number of severe and moderate injuries resulting from e-cigarette explosions and fires since 2014. The USFA noted that this appears to correlate well with the e-cigarette sales trend.
Graphic from a July 2016 United States Fire Administration (USFA) report entitled Electronic Cigarette Fires and Explosions in the United States 2009 – 2016. There has been an increase in the number of severe and moderate injuries resulting from e-cigarette explosions and fires since 2014. The USFA noted that this appears to correlate well with the e-cigarette sales trend.

The United States Fire Administration reported 195 occasions of e-cigarette fires and explosions between January 2009 and December 2016. These incidents resulted in 133 acute injuries, of which 38 (29%) were severe. A 2017 review concluded that 80% of e-cigarette explosions occurred during battery charging, many by 3rd-party power adaptors that used inappropriately high charge rates that led to thermal runaway. Some vendors assembled e-cigarettes from incompatible parts.

E-cigarette device explodes in man's pocket while on bus in California.
An image of a skin burn to the medial right thigh above the knee of a 35-year-old male.
A 35-year-old otherwise healthy male sustained a 2% total body surface area burn to his right lateral thigh when an e-cigarette device in the right back pocket of his pants spontaneously combusted, burning a hole through his pants.

Poisoning

The most common adverse effects in e-cigarette calls to US poison control centers: Ingestion exposure resulted in vomiting, nausea, drowsy, tachycardia, or agitation. Inhalation/nasal exposure resulted in nausea, vomiting, dizziness, agitation, or headache. Ocular exposure resulted in eye irritation or pain, red eye or conjunctivitis, blurred vision, headache, or corneal abrasion. Multiple routes of exposure resulted in eye irritation or pain, vomiting, red eye or conjunctivitis, nausea, or cough. Dermal exposure resulted in nausea, dizziness, vomiting, headache, or tachycardia.
Symptoms of nicotine poisoning related to e-cigarette calls to US poison control centers

E-cigaratte nicotine poisoning occurs via ingestion, inhalation, or absorption via the skin or eyes.

Such poisoning is apparently rare, suggested by the fact that reviews highlight individual cases. In 2014, an infant died from choking on an e-cigarette component. As of 2016 four adults were reported to have died in the US and Europe after intentionally ingesting e-liquid. Two children, one in the US in 2014 and another in Israel in 2013, died after ingesting liquid nicotine. A two-year-old girl in the UK in 2014 was hospitalized after licking an e-cigarette liquid refill.

A 2022 concluded that toxicity can come from aerosols containing toxic chemicals or excessive concentrations of nicotine as an e-liquid.

A 2016 study reported minor, moderate, and serious adverse effects. Minor effects correlated with e-liquid poisoning were tachycardia, tremor, chest pain and hypertension. More serious effects were bradycardia, hypotension, nausea, respiratory paralysis, atrial fibrillation and dyspnea. Initial symptoms included rapid heart rate, sweating, feeling sick, and vomiting. Delayed symptoms included low blood pressure, seizures, and hypoventilation. Rare serious effects included coma, seizure, trouble breathing, and heart attack. After examining poison control centers' reports between 2010 and early 2019, FDA reported that, between the poison control centers and FDA, 35 cases of seizures mentioned use of e-cigarettes.

From 2011 to 2019, cases of accidental poisoning from nicotine e-liquids grew rapidly in the US. From 1 September 2010, to 31 December 2014, 58% of e-cigarette calls to US poison control centers were related to children under 6. In 2014 Centers for Disease Control and Prevention (CDC) reported that 51.1% of the calls to US poison centers due to e-cigarettes were related to children under age 5, and while 42% of calls were related to people age 20 and older. Severe outcomes were more than 2.5 times more frequent in children exposed to e-cigarettes and nicotine e-liquid than with traditional cigarettes.

US poison control centers reported that 92.5% of children who came in contact with nicotine e-liquid swallowed it during the period from January 2012 to April 2017.

Most frequent adverse effects from ingestion
Effect Frequency (%)
vomiting 40.4
eye irritation or pain 20.3
nausea 16.8
red eye or conjunctivitis 10.5
dizziness 7.5
tachycardia 7.1
drowsiness 7.1
agitation 6.3
headache 4.8
cough 4.5

In 2016 American Association of Poison Control Centers (AAPCC) reported 2,907 exposures regarding e-cigarettes and liquid nicotine. The yearly nicotine exposure rate in the US involving children went up by 1,398% from 2012 to 2015, later dropping by 20% from 2015 to 2016. In 2017 the National Poison Data System stated that exposures to e-cigarettes and liquid nicotine among young children was rising significantly.

Respiratory

E-cigarettes are associated with asthma and other respiratory diseases. A 2015 review concluded that e-cigarettes may induce acute lung disease.

A 2018 study reported correlations between vaping and pleural effusions. A 2015 study reported that e-cigarette vapors can induce oxidative stress in lung endothelial cells. A 2016 review concluded that e-cigarette vapor that triggered constant lung inflammation could result in lung pathogenesis and induce diseases such as chronic obstructive pulmonary disease and fibrosis. A 2018 review concluded that e-cigarette vapors can result in acute endothelial cell injury, but the long-term effects were uncertain.: Summary, 7  A 2017 review concluded "Exposure to nicotine that was specifically generated by the use of e-cigarettes, was shown to promote oxidative stress and impairment of autophagy, which in turn serves as a potential mechanism leading to development of chronic obstructive pulmonary disease." A 2014 case report observed the correlation between sub-acute bronchiolitis and vaping. After quitting vaping the symptoms improved. Vaping causes bronchospasm. Adolescents who vaped had a higher frequency of chronic bronchitis symptoms.

A 2018 study reported that adolescent vapers with asthma or other respiratory ailments could have greater odds of increasing respiratory symptoms and aggravations.: Vulnerable/Susceptible Populations, Cystic Fibrosis, 448  In 2018 PHE reported "There have been some studies with adolescents suggesting respiratory symptoms among EC experimenters. However, small scale or uncontrolled switching studies from smoking to vaping have demonstrated some respiratory improvements.": 174  A 2017 review concluded "among a population of 11th-grade and 12th-grade students in California, vaping was associated with twice the risk of respiratory symptoms, and the risk increased with more frequent e-cigarette use."

E-cigarette particles are small enough to enter the alveoli and to go deep in the lungs and enter into systemic circulation. A 2017 study reported that vapor containing particulate matter with a diameter of 2.5 μm enters the circulation via the cardiopulmonary system, with a large deposit in the respiratory tract. A 2014 review concluded that metal nanoparticles can deposit in the alveolar sacs with possible pulmonary toxicity. A 2015 study reported that particle sizes differ across devices with impacts on respiratory tract depositions, and without regard to e-liquid.

A 2018 review concluded that exposure to vapor has adverse effects on lungs and pulmonary function. Repeated acrolein exposure causes chronic pulmonary inflammation, reduction of host defense, neutrophil inflammation, mucus hypersecretion, and protease-mediated lung tissue damage, which are linked to the development of chronic obstructive pulmonary disease (COPD). Although e-cigarette aerosol also exposes users to highly oxidizing free radicals, their chemical characteristics is unclear.

It further reported that vapers experienced decreased expression of immune-related genes in their nasal cavities, more so than smokers. By contrast, vaping upregulates expression of platelet-activating factor receptor (PAFR) in nasal epithelial cells; PAFR is an important molecule involved in the ability of S. pneumoniae, (leading cause of bacterial pneumonia), to attach to cells.

A 2020 study reported that vaping led to lung injuries that include hypersensitivity pneumonitis (HP), diffuse alveolar hemorrhage (DAH), acute eosinophilic pneumonia (AEP), diffuse alveolar damage, organizing pneumonia (OP), lipoid pneumonia, and giant cell interstitial pneumonia (GIP). A 2016 study reported that adverse effects may include airway resistance, irritation of the airways, eyes redness, dry throat, and increase in allergic airway inflammation with elevated infiltration of inflammatory cells including eosinophils into airways. A 2015 study reported that the most reported short-term adverse effects were mouth and throat irritation, dry cough, and nausea. Another 2016 study reported nose bleeds, change in bronchial gene expression, release of cytokines and proinflammatory mediators.

Youth

A 2016 review concluded that nicotine exposure harms youths' growing brains. Vaping is associated with a positive association of vaping and chronic bronchitis among US high school juniors and seniors; which persisted among former users. Vaping was associated with an increased diagnosis of asthma and asthma-related school absences among Korean never-smoker high school students. A 2018 review concluded that child vapers had a higher likelihood of more and more significant adverse effects than child smokers. Significant harmful effects included cyanosis, nausea, and coma.

A 2020/21 survey of 39,214 young people (aged 16 to 19) from the US, Canada, and England found that those who vaped were more likely to have breathing issues (breathlessness, wheezing, chest pain, phlegm, and cough) than those who did not. Also, the more young people vaped, the higher their chance of breathing issues.

2019–2020 vaping lung injury outbreak

This section is an excerpt from 2019–2020 vaping lung illness outbreak.[edit]

An outbreak of e-cigarette, or vaping, product use-associated lung injury began in 2019 among users of illegal, unregulated cannabis vaping products, almost exclusively in the United States. The first cases were identified in Illinois and Wisconsin in April 2019; as of 18 February 2020, a total of 2,807 hospitalized cases, including 68 deaths, had been confirmed. According to the U.S. Centers for Disease Control (CDC), "Vitamin E acetate is strongly linked to the outbreak...Evidence is not sufficient to rule out the contribution of other chemicals of concern, including chemicals in either THC or non-THC products".

Cases peaked in September 2019, and declined thereafter. The decline led CDC to stop reporting cases in February 2020, but as of December 2020, continued to monitor cases arriving in emergency departments. Some states continued to record new cases. As of January 2022, California had reported at least 40 cases diagnosed after February 2020. As of March 2022, cases continued to be diagnosed. At least 73 cases were diagnosed in Utah after February 2020.

CDC investigators identified direct exposure to chemicals present in illegal cannabis vaping products as the likely culprit, but did not rule out chemicals in nicotine vapes as possible causes. CDC: "No specific e-cigarette device or substance has been linked to all cases, and e-cigarettes include a variety of chemical and additives". 84% of patients studied by the CDC reported THC use. The majority of those affected were adults aged 18–34, the biggest cannabis vapers in the US.

Cardiovascular

Reported risks include exposure to toxic chemicals, increased likelihood of respiratory and cardiovascular diseases, reduced lung function, reduced cardiac muscle function, and increased inflammation. A 2018 review concluded that the specific role of nicotine in cardiovascular disease had not been established.

A 2023 review concluded that vaping causes significant, potentially harmful effects on many cardiovascular parameters. A 2024 review attributed cardiovascular effects to oxidative stress, inflammation, endothelial dysfunction, atherosclerosis, hemodynamic effects, and platelet function. A 2019 review reported limited evidence of vaping's adverse impacts on endothelial function and arterial hardening. A 2017 review concluded that vaping could exacerbate adverse cardiovascular effects among those who already have cardiovascular disease. Studies of aldehydes, particulates, and flavorings reported mixed impacts on cardiovascular health. A 2017 review stated that low amounts of aldehydes are a health concern, particularly among individuals with cardiovascular disease. Vaping is associated with heart failure. A 2017 review concluded that vapor particles can enter circulation via the airways.

Many vapor components impact atherosclerosis.

A 2016 review concluded that vaping generates sympathomimetic effects. A 2016 review concluded that there could be a risk for conditions such as tachycardia-induced cardiomyopathy. A 20154 clinician's review reported that short-term effects included increases in blood pressure and heart rate. A 2017 review concluded that these increases among smokers who vaped was lower than with smoking. A 2016 study reported vaping increased aortic stiffness in people with no cardiovascular risk factors, and that the increase was lower than smoking. A 2017 review concluded that habitual vaping was associated with oxidative stress and a shift towards cardiac sympathetic activity, which are both associated with a risk of developing cardiovascular disease. A 2017 review highlighted an association between 2.5 μm particulate exposure and cardiovascular disease.

A 2018 review noted that nicotine is not the only biologically active component in e-cigarette aerosol. Vapor particles are of broadly similar size to those in traditional cigarettes. These particles can be biologically active, trigger inflammatory processes, and are directly implicated in causing cardiovascular disease and acute cardiovascular events. Their dose-response effect is nonlinear, with substantial increases in cardiovascular risk with even low exposure levels. Vapor induces platelet activation, aggregation, and adhesion, which are associated with increased cardiovascular risk. These changes produce rapid deterioration of vascular function. E-cigarette and traditional cigarette smoking in individuals with no known cardiovascular disease exhibit similar inhibition of artery dilation in response to the need for more blood flow. This change reflects damage to vascular endothelium and increases the risk of long-term heart disease and an acute event such as a myocardial infarction (heart attack). Vaping is accompanied by a shift in balance of the autonomic (reflex) nervous system toward sympathetic predominance, which is also associated with increased cardiac risk. Daily vaping is correlated with an increased risk of myocardial infarction in health surveys.

Gastrointestinal (GI) system

A mucosal intestinal barrier separates the external and internal environments within the body. This barrier allows water, ions, solutes, and nutrients to cross the barrier while excluding bacteria and toxins. Tight junctions (TJ) help with the construction and permeability of the barrier in the gut by firmly securing joints. Chronic, repetitive exposure to e-cigarettes damages this barrier by breaking the TJs, which causes gut inflammation, assage of bacteria. altering gene expression. A 2021 study reported that chronic use of nicotine-free e-cigarettes still caused inflammation and decreased TJ markers.

A 2022 study reported that common GI health effects include nausea, vomiting, gastrointestinal discomfort, xerostomia, oral mucositis, gum bleeding, gingivitis, gastric burning, altered bowel habits, and acid reflux. Chronic exposure also drives inflammation in the colon.

Nervous system

A 2024 review concluded that nicotine exposure has detrimental effects on the nervous system, especially during adolescence. Exposure during developmental stages changes brain structure and function. Vaping is linked to impairment of cognitive processes, increased mood disorders and addiction, damage to functions such as memory, reasoning, impulse control, and attention. A 2020 study reported lower gene expression, reducing occludin, which compromises the stability and strength of the blood-brain-barrier, resulting in neurovascular dysfunction, neuroinflammation, and cognitive defects.

Oral cavity

A 2018 review reported little evidence indicating that vaping is less damaging than smoking for periodontal disease: Summary, Conclusion 12-1., 9  and can lead to increased risk of periodontal disease. A 2017 review concluded that nicotine and flavorings may damage periodontal ligaments, stem cells, and gingival fibroblasts in cultures from aldehydes and/or carbonyls from vapor. A 2016 clinicians guide state that e-cigarettes could harm the periodontium because of the effects of nicotine on gum tissues and the immune system. A 2021 study reported that vaping resulted in nicotine stomatitis, hairy tongue, angular cheilitis, and oral mucosal lesions E-cigarettes seems to not be implicated in oral cancer.

Public health effects

Various studies rate the public health impacts of vaping as far less negative than those of smoking.

Second-hand vapor

E-cigarette emissions are not comparable to cigarette smoke as their chemical composition is completely different. Vapor content varies depending on the e-liquid, the device, and usage. : 84  Exhaled vapor consists of mixtures of nicotine, ultrafine particles, primarily propylene glycol, glycerin, flavorings, and aroma transporters, aldehydes, and volatile organic chemicals (VOC) that form a visible fog. The vapor has a half-life of about 10 seconds; smoke lasts 100 times longer. E-cigarettes produce similar levels of particulates to tobacco cigarettes.

Vapor particles are larger than smoke particles, with a mean droplet size of 600 nm (inhaled) and 300 nm (exhaled) along with particles with a diameter of around 2.5 μm. Exhaled vapor concentration is 5 times lower than cigarette smoke. Particle density measured 6 to 880 times lower.

One 2015 study reported that exhaled vapor might have significant adverse effects. Another reported that e-cigarettes that do not contain nicotine may also generate hazardous vapors and could present a second-hand risk. A third reported that vapor may include propylene glycol aerosols at levels that can cause eye and respiratory irritation and exceed California Environmental Protection Agency standards. A 2017 study reported that people living with e‐cigarette users had increased salivary nicotine concentrations. Another reported that some non-users reported adverse effects from second-hand vapor.

A 2016 survey reported that nearly half of middle and high school students had been exposed.

A 2017 review concluded that the few studies that examined the effect of indoor air quality on human test subjects in natural settings produced inconsistent results. As of 2018 only limited information of the effects of exhaled vapor on children was available.

Aerosol (vapor) exhaled by an e-cigarette user may expose non-users to second-hand vapor.
Aerosol (vapor) exhaled by a vaper may expose non-users to second-hand vapor.

A 2018 study reported PM2.5 levels in a large hotel event room (4,023m3) increased from 2–3 μg/m3 to as high as 819 μg/m3 (interquartile range: 761–975 μg/m3) when 59–86 people were vaping. This level exceeded the US Environmental Protection Agency annual time-weighted standard for PM2.5 of 12 μg/m3.

A 2018 review concluded that bystanders absorb nicotine when people around them use e-cigarettes at levels comparable with exposure to second-hand smoke. It included a study comparing non-smokers living with vapers, with smokers, and non-users (controls). That study found cotinine (a nicotine metabolite) levels in urine were significantly elevated in the first two groups vs the controls, but were not significantly different, despite the fact that air pollution levels in the smokers' homes was much higher than in the vapers' homes (geometric mean air nicotine concentrations of 0.13 μg/m3 in vapers' homes, 0.74 μg/m3 in smokers' homes, and 0.02 μg/m3 in the control homes). A 2014 practice guideline by NPS MedicineWise stated that serum cotinine levels were similar in bystanders exposed to either vapour or smoke.

In 2014, several groups came out against e-cigarettes. The International Union Against Tuberculosis and Lung Disease stated, "Adverse health effects for exposed third parties (second-hand exposure) cannot be excluded because the use of e-cigarettes leads to emission of fine and ultrafine inhalable liquid particles, nicotine and cancer-causing substances into indoor air." The American Industrial Hygiene Association concluded that "e-cigarettes are not emission-free and that their pollutants could be of health concern for users and those who are exposed secondhand....[T]heir use in the indoor environment should be restricted, consistent with current smoking bans, until and unless research documents that they will not significantly increase the risk of adverse health effects to room occupants." Similarly, in 2016 the American Society of Heating, Refrigeration and Air-Conditioning Engineers (ASHRAE) updated its standard for "Ventilation for Acceptable Indoor Air Quality" to incorporate emissions from e-cigarettes into the definition of "environmental tobacco smoke," which is incompatible with acceptable indoor air quality. A 2017 French "experts statement" recommended banning vaping indoors in public and working areas.

A 2014 WHO report stated passive exposure was a concern, indicating that current evidence is insufficient to determine whether the levels of exhaled vapor are safe to involuntarily exposed bystanders. The report stated that "it is unknown if the increased exposure to toxicants and particles in exhaled aerosol will lead to an increased risk of disease and death among bystanders." A 2016 WHO report stated, "While some argue that exposure to SHA [second-hand aerosol] is unlikely to cause significant health risks, they concede that SHA can be deleterious to bystanders with some respiratory pre-conditions. It is nevertheless reasonable to assume that the increased concentration of toxicants from SHA over background [air] levels poses an increased risk for the health of all bystanders.": 4 

Several medical organizations advocate that vaping be banned in public places and workplaces. A 2014 review concluded it is safe to infer that their effects on bystanders are minimal in comparison to traditional cigarettes. E-cigarette vapor has notably fewer toxicants than cigarette smoke.

A no smoking or vaping sign from the US
A no smoking or vaping sign from the US

A 2015 California Department of Public Health report stated that vapour "has been reported to contain at least ten chemicals that are on California's Proposition 65 list of chemicals known to cause cancer, birth defects, or other reproductive harm.": 1 

A 2017 study reported that some chemicals could violate workplace safety standards. A review of convention studies concluded that second-hand vapor may be significant, particularly for workers who repeatedly encounter it. Exposure studies suggest that indoor vaping is higher than the smoke-free level put forth by the US Surgeon General and the WHO Framework Convention on Tobacco Control.: Secondhand Exposure to E-Cigarette Aerosol, Synthesis, 84 

A 2014 review suggested that vapor contaminant levels do not exceed workplace safety standards, and are mostly below 1% of permissible levels. However, workplace standards do not consider more vulnerable groups such as those in poor health, children, and infants. 2 015 PHE report concluded that e-cigarettes "release negligible levels of nicotine into ambient air with no identified health risks to bystanders".: 65 

Direct exposure

Direct exposure happens via e-liquid inhalation, ingestion, skin contact, or vapor residue accumulation on surfaces. Direct exposure is almost always inadvertent, and results from improper product use. Exposure can involve much higher concentrations than exhaled vapor.

Exposure may involve a leaking or spilled e-liquid cartridge or bottle.

E-liquid quickly absorbs into the skin and local irritation can follow. Less than 1 tablespoon can cause adverse effects such as seizures, anoxic brain trauma, vomiting, lactic acidosis,: Summary, Conclusion 14-2., 9  cardiac arrest, seizures, or coma. A potentially fatal dose for a child is 0.1–0.2 mg/kg of body weight, or 6 mg. A fatal dose for an adult is 0.5–1 mg/kg or about 30–60 mg. However the widely used human LD50 estimate of around 0.8 mg/kg was questioned in a 2013 review, in light of documented cases of humans surviving much higher doses; the lower fatal limit was 500–1000 mg of ingested nicotine, which is equivalent to 6.5–13 mg/kg orally.

Vapor build-up

E‐cigarettes can be unsafe to non-users via third-hand exposure, including children, pregnant women, nursing mothers, casino employees, housekeeping employees, and vulnerable groups.

In one scenario, indoor surfaces can accumulate nicotine-laden vapor residue. However, the extent of such contamination has not been established. A 2015 PHE report stated that an infant would have to lick 30 square meters to be exposed to 1 mg of nicotine.: 65  As with any potential hazard, childhood exploratory behavior creates risks not faced by others.

Risks to children

Children are more likely to mistake a colorful e-liquid container for a juice container. The US mandates child-proof packaging.

Self-harm

As of 2019 a few incidents of intentional self-harm by ingesting or injecting e-liquids had been reported. Death from intentional nicotine poisoning is almost unknown.: 63 

Pets

In 2017, FDA stated that e-cigarette aerosols can cause problems for both users and their pets. Some studies reported that aerosols may provide exposure to higher-than-normal amounts of nicotine and other toxic chemicals, such as formaldehyde. E-cigarettes typically use capsules to contain nicotine. Pets may find and bite them or expose themselves to the liquid refilling solution. In a 15 March 2016, letter to the editor of the Journal of the American Veterinary Medical Association, the Texas Poison Center Network reported 11 cases of dog exposures to e-cigarettes or refills.

Toxicology

The long-term health impacts of vaping are unknown, particularly given the variety of EC devices, e‑liquids, and consumption patterns. This specifically applies to nicotine and propylene glycol. Limited peer-reviewed data restricts the scope of toxicological evaluation; their cytotoxicity is unknown. A 2014 review concluded that few e-cigarettes had undergone a thorough toxicology evaluation and testing.

Toxicant comparisons

E-cigarettes supply nicotine and other toxins at rates far below traditional cigarettes and other nicotine delivery systems:

E-cigarette toxicants compared with nicotine inhaler and cigarette smoke
Toxicant Nicotine inhaler mist

(15 puffs∗)

 E-cigarettes

(15 puffs∗)

 1 cigarette
Formaldehyde (μg) 0.2 0.2-5.61 1.6-52
Acetaldehyde (μg) 0.11 0.11-1.36 52-140
Acrolein (μg) ND 0.07-4.19 2.4-62
o-Methylbenzaldehyde (μg) 0.07 0.13-0.71 —
Toluene (μg) ND ND-0.63 8.3-70
p- and m-Xylene (μg) ND ND-0.2 —
NNN (ng) ND ND-0.00043 0.0005-0.19
Cadmium (ng) 0.003 ND-0.022 —
Nickel (ng) 0.019 0.011-0.029 —
Lead (ng) 0.004 0.003-0.057 —

DNA damage

Nicotine has been reported to damage DNA, assessed by the Escherichia colipol A+/pol− test. A 2015 review concluded that nicotine decreases Chk2, a tumor suppressor, which is otherwise activated by DNA damage. The Chk2 decrease suggests nicotine may be able to override DNA damage checkpoint activation, disrupt genetic surveillance, and increase the risk of oncogenesis. One 2018 study reported strong evidence that some vapor substances such as formaldehyde and acrolein can induce DNA damage and mutagenesis.: Summary, Conclusion 10–4., 8 

Nicotine can induce chromosomal aberration, chromatid exchange, single-strand DNA strand breaks, and micronuclei in vitro. Oxidative stress is likely involved, since the effects are reduced when antioxidants are present. The effects decrease after co-incubation with a NAR antagonist, indicating a receptor-dependent pathway for oxidative stress induction.

Vapor triggered DNA strand breaks and lowered cell survival in vitro, regardless of nicotine content. A 2013 study reported that some vapor samples had cytotoxic effects on cardiac muscle cells, (albeit less than those of cigarette smoke). A 2016 review concluded that vapor had adverse effects on primary airway epithelial cells and tumor cell lines, and other epithelial cell lines, that ranged from reducing viability, increase in production of inflammatory mediators and oxidative stress, reduced antimicrobial defences and increased pro-carcinogenic events.

Chart showing various toxicants as measured in cigarette smoke and e-cigarette aerosol.
Chart showing various toxicants as measured in cigarette smoke and e-cigarette aerosol

Propylene glycol and glycerin

An image of the propylene glycol molecule
The propylene glycol molecule

The primary base ingredients of e-liquids are propylene glycol and glycerin. About 20% to 27% of propylene glycol and glycerin-based liquid particles are inhaled. A 2016 study reported that 6% of nicotine, 8% of propylene glycol, and 16% of glycerin was exhaled.: 162  As of 2014 the long-term effects of inhaled propylene glycol and glycerin were unknown. Exposure to propylene glycol may cause eye and respiratory tract irritation. Heated and aerosolized propylene glycol can turn into propylene oxide, which the International Agency for Research on Cancer (IARC) labels a possible human carcinogen. A 2014 review concluded that the risk from propylene glycol and glycerin inhalation is probably low, although they have not been demonstrated to be safe. A 2013 German Cancer Center report stated that long-term indoor inhalation of propylene glycol could increase childhood asthma risks. As of 2014, some companies replaced propylene glycol with water and glycerin. A 2019 study reported that inhaled glycerin could cause lipoid pneumonia. A 2017 review concluded that propylene glycol and glycerin increased the amount of hydrogen peroxide.[clarification needed]

Acrolein

Some e-liquids produced acrolein in the aerosol (a probable carcinogen), possibly from heated glycerin. A 2014 review concluded that acrolein levels were reduced by 60% in dual users and 80% for those that completely switched to e-cigarettes when compared to traditional cigarettes. Another 2014 review concluded that acrolein may induce irritation to the upper respiratory tract, while a 2014 study reported harm to the lining of the lungs. A 2017 review concluded that acrolein induces oxidative stress and inflammation, disrupting lung endothelial cell barrier function and may lead to chronic obstructive pulmonary disease. Another 2017 review stated, "based on the average of 120 puffs/day reported in the literature, our calculated levels of acrolein emitted by e‐cigarette users per day were reported to vary between 0.00792 and 8.94 ppm/day."

Oxidants/reactive oxygen species

A 2015 study reported that vapor created oxidants and reactive oxygen species (OX/ROS). OX/ROS could react with other vaporized substances because they are highly reactive. E-cigarettes were reported to contain OX/ROS at about 100 times less than in cigarette smoke. Recent in vitro research has demonstrated that nicotine-free e-cigarette vapor induces oxidative stress in human endothelial cells via activation of ARF6 and its guanine nucleotide exchange factor ARNO. This oxidative stress promotes abnormal angiogenic signalling and endothelial dysfunction, suggesting that vaping without nicotine may still contribute to vascular injury through reactive oxygen species pathways. Similar findings have been reported with nicotine-containing e-cigarette condensate, indicating that both nicotine-free and nicotine-containing vaping fluids can disrupt pulmonary endothelial function via ARF6-mediated mechanisms.

Flavorings

The ingredients in an e-cigarette cartridge: Distilled water, Nicotine, FCC Grade Vegetable Glycerin, Natural Flavors, Artificial Flavors, Citric Acid. Nicotine content 6–8 mg per cartridge.
The ingredients in an e-cigarette cartridge: Distilled water, Nicotine, FCC Grade Vegetable Glycerin, Natural Flavors, Artificial Flavors, Citric Acid. Nicotine content 6-8 mg per cartridge.

Flavored e-liquids contain additional substances in part to disguise nicotine's bitter taste. Their health effects are not entirely known, given limited toxicological data. A 2017 study reported that flavorings can be a significant part of toxicants. Each flavoring has a different chemical composition. A 2015 study reported varied cytotoxicity of e-liquids, ranging from little to significant cytotoxicity. The liquids contain aromatic substances such as tobacco, fruit, vanilla, caramel, and coffee. Typically, these additives are imprecisely described, using terms such as "vegetable flavoring". Although they are approved for human consumption no studies assess the short-term or long-term effects of inhaling them. As of 2016 their safety had not been assessed by the US Flavor and Extract Manufacturers Association (FEMA). As of 2018 the majority of flavorings in e-liquids had not been investigated for inhalation toxicity.: Summary, 4  A 2017 review stated that FEMA had identified 1037 flavoring agents as potential respiratory hazards due to volatility and respiratory irritant properties. Common flavoring agents on that list include diacetyl, acetoin, 2,3-pentanedione (buttery), camphor and cyclohexanone (minty), benzaldehyde (cherry or almond), cinnamaldehyde (cinnamon), cresol (leathery) or medicinal (chocolate), and isoamyl acetate (banana). As of 2017 the four most commonly reported flavoring additives were vanillin, ethyl maltol, ethyl vanillin, and menthol. A 2017 review stated, "the implication by manufacturers that flavoring ingredients used in e-cigarettes and related devices (e.g. hookahs) are safe for inhalation because they have FEMA GRAS™ status for use in food has been stated to be 'false and misleading' by FEMA."

Many flavorings are irritants. : 3  The limited available data suggest that the majority of flavorings could lead to significant health risks from long-term use, particularly those that are sweet. Some e-liquids contain large amounts of flavorings. A 2016 study of 30 e-cigarette products in the US market reported that 13 were more than 1% flavoring chemicals by weight, some of which were of potential toxicological concern (e.g., cause respiratory irritation). Some flavorings are toxic and some resemble known carcinogens. A 2016 study of five flavorings across six types of e-cigarettes reported that flavorings significantly affected the in vitro toxicity profile. Some artificial flavorings are known cytotoxins. Unflavored vapor is less cytotoxic than flavored vapor.: 82  The evidence is unclear that particular flavorings carry health risks, though some may increase such risks.: 19 

Cinnamaldehyde has been described as highly cytotoxic. Cinnamaldehyde has been detected in flavorings such as cinnamon, tobacco, sweet (e.g. caramel), and fruit.: Exposure to Flavorings, 175  Coffee and cinnamon flavorings are reported to be the most toxic. A 2017 review concluded that they were carcinogenic or toxic, and could contribute to cardiopulmonary diseases and neurodegenerative disorders. Only sparse evidence directly associates cinnamon inhalations with asthma. Some e-liquids containing cinnamaldehyde stimulate TRPA1, which might induce effects on the lung. In human lung fibroblasts, cinnamon roll flavoring resulted in a noticeable rise in the amount of inflammatory cytokine IL-8.

A 2019 case report described an 18-year-old patient using a Juul device with mint-flavored pods in the days before episodes of pneumothorax. A 2019 study that sampled e-cigarette delivery systems reported that Juul pods were the only product to demonstrate in vitro cytotoxicity from both nicotine and flavoring chemical content, in particular ethyl maltol. As of 2017 limited data described the effects of menthol inhalation. Some flavorings may increase lung toxicity or lung inflammation in part by producing free radicals and inflammation.

E-liquids contain possibly toxic aldehydes and reactive oxygen species (ROS). Many flavorings are known aldehydes, such as anisaldehyde, cinnamaldehyde, and isovaleraldehyde. Saccharides in sweet e-liquid flavorings generate furans and aldehydes when vaporized.: FLAVORINGS, 172  The consequences of aldehyde-containing flavorings on pulmonary surfaces are unknown. Methanol increased the amount of hydrogen peroxide. A 2017 study reported a variety of flavoring-initiated inflammatory cytokines in lung cell cultures, of which acetoin and maltol were among the strongest. It is possible that flavorings may worsen harmful effects such as diminished cell viability, escalated rates of apoptosis, escalated DNA strand breaks, alterations in cell morphology and intensified inflammatory mediator production.

Although there were concerns in the 2010s, vaping does not cause popcorn lung. Cherry flavorings contain a benzaldehyde, a main ingredient for many fruit flavorings. Benzaldehyde can irritate the eyes and respiratory mucous membranes.

Formaldehyde

IARC categorized formaldehyde as a human carcinogen, and acetaldehyde is categorized as a potential human carcinogen. Formaldehyde induced DNA damage and inhibited DNA repair. Acetaldehyde generated DNA crosslinking, which impedes metabolic functions, including DNA replication, repair, recombination, transcription and chromatin remodeling. Aldehydes may cause harm. A 2016 study reported that e-liquids without flavoring generated no aldehydes, which indicated that flavorings were causing the creation of aldehydes, according to a 2018 PHE report.: 160 

Chemicals can be inadvertently produced, especially carbonyls such as formaldehyde, acetaldehyde, acrolein, and glyoxal when the nichrome wire (heating element) reaches a high enough temperature. Potentially hazardous carbonyls have been identified in aerosols at temperatures above 200 °C.

A 2017 study reported that battery output voltage positively influenced carbonyl vapor levels. A 2015 study reported that e-cigarettes using higher voltages (5.0 V) can emit carcinogens including formaldehyde at levels comparable to cigarette smoke, while lower voltages (3.0 V) produce levels of formaldehyde and acetaldehyde roughly 13 and 807-fold less than in cigarette smoke. Elevated aldehyde formation has an unpleasant taste, leading users to avoid it. The average amount of formaldehyde in vapor from high-voltage devices is higher than the average from cigarettes.

The amount of formaldehyde expected to be inhaled by the user is disputed. In 2015 PHE reported that normal vaping generates low levels of aldehydes. Normal usage also generates low levels of formaldehyde.: 77, 82  However, users detect and avoid the "dry puff", leading them to conclude, "There is no indication that EC users are exposed to dangerous levels of aldehydes.": 77–78  In 2018 PHE reported that at normal temperatures, aldehyde levels were negligible compared with smoke.: 158 

Nicotine

This section is an excerpt from Nicotine § Adverse effects.[edit]
Possible side effects of nicotine

Nicotine is classified as a poison, and it is "extremely hazardous". The CDC says it is "toxic to developing fetuses and is a health danger for pregnant women." It can harm brain development up to age twenty-five, and early use of nicotine can predispose young people to smoking and drug use. However, at doses typically used by consumers, it presents little if any hazard to adult users. Although at low amounts nicotine has a mild analgesic effect, at sufficiently high doses nicotine may result in nausea, vomiting, diarrhea, salivation, bradycardia, and possibly seizures, hypoventilation, and death.

Cigarettes and nicotine replacement products

E-cigarettes increase serum nicotine levels quicker than nicotine replacement products, but more gradually than traditional cigarettes.

A 2017 study reported that vaping produced comparable levels of nicotine urinary metabolites to tobacco and smokeless tobacco products. However, oxidative nicotine metabolites were less in vapers.

A 2017 review concluded that some vaping products delivered the same amount of nicotine as traditional cigarettes.

In 2018 the National Academies of Sciences, Engineering, and Medicine reported that the degree of dependence is less for e-cigarettes than traditional cigarettes.: Summary, Conclusion 8-2., 7 

Aerosol composition

The chemical composition of e-cigarette aerosols varies. E-cigarette aerosol is generated when the e-liquid reaches a temperature of roughly 100–250 °C within a chamber, which causes pyrolysis and possible decomposition of other liquid ingredients. The levels of nicotine, TSNAs, aldehydes, metals, volatile organic compounds (VOCs), flavorings, and tobacco alkaloids in e-cigarette vapors vary greatly. The yield of chemicals reported in the e-cigarette vapor varies depending on, several factors, including the e-liquid contents, puffing rate, and the battery voltage.

E-cigarettes consist of fine and ultrafine particles of particulate matter, in the form of an aerosol. The aerosol (mist) produced by an e-cigarette is commonly but inaccurately called vapor. In physics, a vapor is a substance in the gas phase whereas an aerosol is a suspension of tiny particles of liquid, solid or both within a gas. The word "vaping" is not technically accurate when applied to e-cigarettes. The aerosol is made-up of liquid sub-micron particles of condensed vapor; thus, the users of these devices are rather "aerosolizing." This aerosol that is produces looks like cigarette smoke to some extent. After a puff, inhalation of the aerosol travels from the device into the mouth and lungs. The composition of e-liquids varies widely due to the extensive range of nicotine levels and flavoring additives used in these products, which result in a variety of chemical combinations.

Metals

Metals including nickel, cadmium, lead, chromium, tin, and silicate have been reported in e-cigarette vapor. The device could contribute small amounts of metals in the liquid and vapor, because their metal parts contact the e-liquid.

A 2018 PHE report stated, "[e-cigarettes] that generate minimal metal emissions should become an industry standard.": 162 

A 2016 study reported that metals can be carcinogenic, nephrotoxic, neurotoxic, and hemotoxic. A 2018 study reported that copper nanoparticles can induce mitochondrial and DNA injury in lung fibroblasts. DNA repair can be impeded by vaporized titanium dioxide nanoparticles as demonstrated by single-strand DNA breaks and oxidative stress in the DNA of A549 cells. Heavy metals are correlated with serious health issues. Inhaling lead can induce serious neurologic injury, notably to the growing brains of children.

A 2016 review concluded that metals reported in vapor may induce cell damage and initiate inflammatory cytokine such as in human lung fibroblasts. A 2017 review concluded, "E-cigarette aerosols and copper nanoparticles induced mitochondrial ROS production, mitochondrial stress (reduced stability of OxPhos electron transport chain (ETC) complex IV subunit) and DNA fragmentation in lung fibroblasts." A 2017 review linked cadmium to low sperm density.

A 2023 review concluded that the evidence about metals in vapor was not sufficient to create a firm conclusion. It highlighted that prior smoking history was not always appropriately considered in these studies due to long half-life for some metals.

First-generation devices

Compared to traditional cigarettes, older devices typically produced much lower blood nicotine levels, although a 2014 study reported plasma nicotine concentration which comparable to that of traditional cigarettes. A 2014 study reported that nicotine delivered from e-cigarettes entered the body slower than traditional cigarettes. A 2014 review concluded that inexperienced users obtained moderate amounts of nicotine from e-cigarettes.

Tank/adjustable devices

Tank or adjustable e-cigarettes, as well as concentrated nicotine liquids, may deliver nicotine at levels similar to traditional cigarettes. A 2017 study reported that nicotine delivery compared to previous generation had increased by 35-72%, elevating heart rates comparable to traditional cigarettes. As of 2017 fourth-generation devices had not been heavily researched.

Concerns

An image of the human brain. The reinforcing effects of drugs of abuse, such as nicotine, is associated with its ability to excite the mesolimbic and dopaminergic systems. How do e-cigarettes affect the brain? The nicotine in e-liquids readily absorbs into the bloodstream when a person uses an e-cigarette. Upon entering the blood, nicotine stimulates the adrenal glands to release the hormone epinephrine (adrenaline). Epinephrine stimulates the central nervous system and increases blood pressure, breathing, and heart rate. As with most addictive substances, nicotine increases levels of a chemical messenger in the brain called dopamine, which affects parts of the brain that control reward (pleasure from natural behaviors such as eating). These feelings motivate some people to use nicotine again and again, despite possible risks to their health and well-being.
The reinforcing effects of drugs of abuse, such as nicotine, is associated with its ability to excite the mesolimbic and dopaminergic systems. How do e-cigarettes affect the brain? The nicotine in e-liquids readily absorbs into the bloodstream when a person uses an e-cigarette. Upon entering the blood, nicotine stimulates the adrenal glands to release the hormone epinephrine (adrenaline). Epinephrine stimulates the central nervous system and increases blood pressure, breathing, and heart rate. As with most addictive substances, nicotine increases levels of a chemical messenger in the brain called dopamine, which affects parts of the brain that control reward (pleasure from natural behaviors such as eating). These feelings motivate some people to use nicotine again and again, despite possible risks to their health and well-being.

The health effects of long-term nicotine use are unknown.[need quotation to verify] While myriad studies have been conducted, many questions remain unresolved, including impurities in e-liquids.: Minor Tobacco Alkaloids, 193 

Youth concerns

Exposure to e-cigarette components in a susceptible time period of brain development could induce persistent behavioral changes. The FDA stated in 2019 that some vapers experienced seizures; most reports involved youth or young adult users.

Pregnancy/lactation

A 2016 review concluded that pregnant/breastfeeding women should not substitute cigarettes with e-cigarettes due to the uncertainty about ingredients. The FDA has not approved e-cigarettes as a smoking cessation aid. One study reported increased irritability among infants in those exposed to e-cigarettes or smoking.

A 2022 study recommended quitting smoking altogether through smoking cessation therapy rather than turning to e-cigarettes as an alternative. The U.S. Preventive Services Task Force (USPSTF) recommended that pregnant women adopt behavioral interventions for quitting. Ecigs vaped by pregnant women may increase copd and asthma risk in offspring.

See also

Notes

  1. ↑ Since 2016 the US Food and Drug Administration (US FDA) regulated e-cigarettes under the classification of tobacco products and labeled them as electronic nicotine delivery systems. A 2018 report commissioned by the US FDA decided to use the term e-cigarettes, indicating that for some use e-liquids containing no nicotine.

References

  1. ↑ Oyella P, et al. Arch Dis Child 2026;0:1–7. doi:10.1136/archdischild-2025-330125
  2. 1 2 3 "E-cigarettes around 95% less harmful than tobacco estimates landmark review". GOV.UK. Retrieved 27 February 2021.
  3. ↑ Lee J, Kim J, Nam H (2025). "Abstract P2022: The Use of Pod-Type Electronic Cigarettes and Recent Asthma Diagnosis in Adolescents". Circulation. 151 cir.151.suppl_1.P2022. doi:10.1161/cir.151.suppl_1.P2022. This study showed that adolescents who used pod-type e-cigarettes had a higher prevalence of asthma than those who did not.
  4. ↑ Song C, Hao X, Critselis E, Panagiotakos D (1 April 2025). "The impact of electronic cigarette use on chronic obstructive pulmonary disease: A systematic review and meta-analysis". Respiratory Medicine. 239 107985. doi:10.1016/j.rmed.2025.107985. ISSN 0954-6111. PMID 39921069. The current meta-analysis highlights that e-cigarette users face an increased risk of developing COPD.
  5. ↑ Wills TA, Soneji SS, Choi K, Jaspers I, Tam EK (10 October 2020). "E-cigarette Use and Respiratory Disorder: An Integrative Review of Converging Evidence from Epidemiological and Laboratory Studies". European Respiratory Journal. 56 (5): 363–380. doi:10.1183/13993003.01815-2019. ISSN 1399-3003. PMC 7817920. PMID 33154031.
  6. 1 2 Malesu VK (27 February 2025). "Vaping while pregnant isn't harmless—study uncovers risks to newborn lung health". News-Medical. Retrieved 7 June 2025.
  7. 1 2 bene a, Mensah SO, Almaadawy O, Dwumah A, Pingili A, Mlilo M, et al. (2 April 2024). "Electronic nicotine product use is associated with incident heart failure - the all of us research program". JACC. 83 (13_Supplement): 695. doi:10.1016/S0735-1097(24)02685-8.
  8. 1 2 3 4 "Electronic cigarettes and health outcomes: systematic review of global evidence" (PDF).
  9. ↑ "Vaping myths and the facts - Better Health". nhs.uk. 13 September 2023. Retrieved 12 July 2025.
  10. 1 2 3 4 5 6 7 Farsalinos KE, Polosa R (April 2014). "Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review". Therapeutic Advances in Drug Safety. 5 (2): 67–86. doi:10.1177/2042098614524430. PMC 4110871. PMID 25083263.
  11. 1 2 3 4 5 6 7 8 Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H (November 2014). "Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit". Addiction. 109 (11): 1801–1810. doi:10.1111/add.12659. PMC 4487785. PMID 25078252.
  12. 1 2 3 4 5 6 7 Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, et al. (February 2015). "Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology". Clinical Cancer Research. 21 (3): 514–525. doi:10.1158/1078-0432.CCR-14-2544. PMID 25573384.
  13. 1 2 Durmowicz EL (May 2014). "The impact of electronic cigarettes on the paediatric population". Tobacco Control. 23 (Supplement 2): ii41–ii46. doi:10.1136/tobaccocontrol-2013-051468. PMC 3995262. PMID 24732163.
  14. ↑ Breland AB, Spindle T, Weaver M, Eissenberg T (2014). "Science and Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 223–233. doi:10.1097/ADM.0000000000000049. ISSN 1932-0620. PMC 4122311. PMID 25089952.
  15. 1 2 3 4 5 6 7 Grana R, Benowitz N, Glantz SA (May 2014). "E-cigarettes: a scientific review". Circulation. 129 (19): 1972–1986. doi:10.1161/circulationaha.114.007667. PMC 4018182. PMID 24821826.
  16. ↑ Hall R (19 August 2026). "Young vapers 'at risk of breathing problems and becoming smokers'". The Guardian.
  17. ↑ CDC (31 January 2025). "Health Effects of Vaping". Smoking and Tobacco Use. Retrieved 1 April 2025.
  18. ↑ "Stop smoking in pregnancy". nhs.uk. 2 December 2020. Retrieved 19 August 2026.
  19. ↑ Rodriguez J, Silverstein D, Mutic A, Liang D, Peterson S, Yang I (9 July 2025). "Passive Electronic Cigarette Vapor Exposure in Children: A Systematic Review". Biological Research for Nursing. 28 (1) 10998004251357832. doi:10.1177/10998004251357832. ISSN 1099-8004. PMID 40631933.
  20. 1 2 3 4 5 6 7 Lindson N, Butler AR, McRobbie H, Bullen C, Hajek P, Wu AD, et al. (29 January 2025). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 1 (1) CD010216. doi:10.1002/14651858.CD010216.pub9. ISSN 1469-493X. PMC 11776059. PMID 39878158.
  21. ↑ Detailed reference list is located at a separate image page.
  22. ↑ Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS (2018). "Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives". Annual Review of Public Health. 39 (1): 193–213. doi:10.1146/annurev-publhealth-040617-013849. ISSN 0163-7525. PMC 6942997. PMID 29323611. This article incorporates text by David B. Abrams, Allison M. Glasser, Jennifer L. Pearson, Andrea C. Villanti, Lauren K. Collins, and Raymond S. Niaura available under the CC BY 4.0 license.
  23. 1 2 Weaver M, Breland A, Spindle T, Eissenberg T (2014). "Electronic Cigarettes". Journal of Addiction Medicine. 8 (4): 234–240. doi:10.1097/ADM.0000000000000043. ISSN 1932-0620. PMC 4123220. PMID 25089953.
  24. 1 2 Cahn Z, Siegel M (February 2011). "Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?". Journal of Public Health Policy. 32 (1): 16–31. doi:10.1057/jphp.2010.41. PMID 21150942.
  25. ↑ Britton J, Bogdanovica I (15 May 2014). "Electronic cigarettes – A report commissioned by Public Health England" (PDF). Public Health England.
  26. ↑ Scherer G (2018). "Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review". Regulatory Toxicology and Pharmacology. 94: 203–233. doi:10.1016/j.yrtph.2018.02.002. ISSN 0273-2300. PMID 29428304.
  27. ↑ Oh AY, Kacker A (December 2014). "Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes?: Review on e-cigarette vapor versus tobacco smoke". The Laryngoscope. 124 (12): 2702–2706. doi:10.1002/lary.24750. PMID 25302452. S2CID 10560264.
  28. ↑ Kundu A, Sachdeva K, Feore A, Sanchez S, Sutton M, Seth S, et al. (28 January 2025). "Evidence update on the cancer risk of vaping e-cigarettes: A systematic review". Tobacco Induced Diseases. 23 (January): 1–14. doi:10.18332/tid/192934. ISSN 1617-9625. PMC 11773639. PMID 39877383.
  29. 1 2 3 4 5 Franck C, Filion KB, Kimmelman J, Grad R, Eisenberg MJ (2016). "Ethical considerations of e-cigarette use for tobacco harm reduction". Respiratory Research. 17 (1): 53. doi:10.1186/s12931-016-0370-3. ISSN 1465-993X. PMC 4869264. PMID 27184265. This article incorporates text by Caroline Franck, Kristian B. Filion, Jonathan Kimmelman, Roland Grad and Mark J. Eisenberg available under the CC BY 4.0 license.
  30. ↑ "Nicotine vaping in England: 2022 evidence update main findings". GOV.UK. Retrieved 7 April 2026.
  31. ↑ "E-cigarettes and harm reduction: An evidence review" (PDF). rcp.ac.uk (pdf). Retrieved 7 April 2026.
  32. ↑ Franks AS, Sando K, McBane S (2018). "Do Electronic Cigarettes Have a Role in Tobacco Cessation?". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 38 (5): 555–568. doi:10.1002/phar.2103. ISSN 0277-0008. PMID 29573440. S2CID 4365503.
  33. ↑ Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H (November 2014). "Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit". Addiction. 109 (11): 1801–1810. doi:10.1111/add.12659. PMC 4487785. PMID 25078252.
  34. ↑ "Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? | Cochrane".
  35. ↑ Traboulsi H, Cherian M, Abou Rjeili M, Preteroti M, Bourbeau J, Smith BM, et al. (15 May 2020). "Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health". International Journal of Molecular Sciences. 21 (10) 3495. doi:10.3390/ijms21103495. PMC 7278963. PMID 32429092.
  36. ↑ Patil S, Arakeri G, Patil S, Ali Baeshen H, Raj T, Sarode SC, et al. (2019). "Are electronic nicotine delivery systems (ENDs) helping cigarette smokers quit? – A current evidence". Journal of Oral Pathology & Medicine. 49 (3): 181–189. doi:10.1111/jop.12966. ISSN 0904-2512. PMID 31642553. S2CID 204850725.
  37. ↑ MacDonald M, O'Leary R, Stockwell T, Reist D (May 2016). "Clearing the air: protocol for a systematic meta-narrative review on the harms and benefits of e-cigarettes and vapour devices". Systematic Reviews. 5 (1) 85. doi:10.1186/s13643-016-0264-y. PMC 4875675. PMID 27209032. This article incorporates text by Marjorie MacDonald, Renee O'Leary, Tim Stockwell, and Dan Reist available under the CC BY 4.0 license.
  38. ↑ "Electronic Cigarettes". Centers for Disease Control and Prevention. 7 September 2017.Public Domain This article incorporates text from this source, which is in the public domain.
  39. ↑ Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. (14 February 2019). "A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy". The New England Journal of Medicine. 380 (7): 629–637. doi:10.1056/NEJMoa1808779. ISSN 0028-4793. PMID 30699054.
  40. 1 2 Pesko M, Saenz C (27 January 2025). "Pharmaceutical Drug Regulation and Mortality: Evidence from E-cigarettes". SSRN 5108105.
  41. 1 2 El Dib R, Suzumura EA, Akl EA, Gomaa H, Agarwal A, Chang Y, et al. (2017). "Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis". BMJ Open. 7 (2) e012680. doi:10.1136/bmjopen-2016-012680. ISSN 2044-6055. PMC 5337697. PMID 28235965.
  42. ↑ Malas M, van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. (25 April 2016). "Electronic Cigarettes for Smoking Cessation: A Systematic Review". Nicotine & Tobacco Research. 18 (10): 1926–1936. doi:10.1093/ntr/ntw119. ISSN 1462-2203. PMID 27113014.
  43. ↑ Vanderkam P, Boussageon R, Underner M, Langbourg N, Brabant Y, Binder P, et al. (2016). "Efficacité et sécurité de la cigarette électronique pour la réduction du tabagisme: revue systématique et méta-analyse". La Presse Médicale. 45 (11): 971–985. doi:10.1016/j.lpm.2016.05.026. ISSN 0755-4982. PMID 27597300.
  44. ↑ Carpenter MJ, Wahlquist AE, Dahne J, Gray KM, Cummings KM, Warren G, et al. (2023). "Effect of unguided e-cigarette provision on uptake, use, and smoking cessation among adults who smoke in the USA: a naturalistic, randomised, controlled clinical trial - PMC". eClinicalMedicine. 63 102142. doi:10.1016/j.eclinm.2023.102142. PMC 10518503. PMID 37753443.
  45. ↑ Al-Hamdani M, Hopkins DB, Park T (2020). "Vaping among youth and young adults: a "red alert" state". Journal of Public Health Policy. 41 (1): 63–69. doi:10.1057/s41271-019-00193-2. ISSN 0197-5897. PMID 31664162. S2CID 204966830.
  46. 1 2 Chatterjee K, Alzghoul B, Innabi A, Meena N (2018). "Is vaping a gateway to smoking: a review of the longitudinal studies". International Journal of Adolescent Medicine and Health. 30 (3) 20160033. doi:10.1515/ijamh-2016-0033. ISSN 2191-0278. PMID 27505084. S2CID 23977146.
  47. ↑ Lucchiari C, Masiero M, Botturi A, Pravettoni G (2016). "Helping patients to reduce tobacco consumption in oncology: a narrative review". SpringerPlus. 5 (1): 1136. doi:10.1186/s40064-016-2798-9. ISSN 2193-1801. PMC 4954805. PMID 27504234.
  48. ↑ Gentry S, Forouhi N, Notley C (2018). "Are Electronic Cigarettes an Effective Aid to Smoking Cessation or Reduction Among Vulnerable Groups? A Systematic Review of Quantitative and Qualitative Evidence". Nicotine & Tobacco Research. 21 (5): 602–616. doi:10.1093/ntr/nty054. ISSN 1462-2203. PMC 6697178. PMID 29608714.
  49. ↑ Hall R (19 August 2026). "Young vapers 'at risk of breathing problems and becoming smokers'". The Guardian.
  50. ↑ Siu AL (22 September 2015). "Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 163 (8): 622–634. doi:10.7326/M15-2023. PMID 26389730.
  51. ↑ Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP (September 2015). "Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force" (PDF). Annals of Internal Medicine. 163 (8): 608. doi:10.7326/M15-0171. ISSN 0003-4819. PMID 26491759. S2CID 207538340.[dead link]
  52. ↑ Caci G, Selya A, La Rosa GR, Spicuzza L, Morjaria JB, Geraci G, et al. (1 March 2025). "Respiratory effects of electronic cigarette use in individuals who never smoked: A systematic review". Clinical Medicine. 25 (2) 100295. doi:10.1016/j.clinme.2025.100295. ISSN 1470-2118. PMC 11930579. PMID 39993529.
  53. 1 2 Drummond MB, Upson D (February 2014). "Electronic cigarettes. Potential harms and benefits". Annals of the American Thoracic Society. 11 (2): 236–242. doi:10.1513/annalsats.201311-391fr. PMC 5469426. PMID 24575993.
  54. ↑ "Using e-cigarettes to stop smoking". nhs.uk. 24 November 2021. Retrieved 15 May 2026.
  55. ↑ Brady BR, De La Rosa JS, Nair US, Leischow SJ (2019). "Electronic Cigarette Policy Recommendations: A Scoping Review". American Journal of Health Behavior. 43 (1): 88–104. doi:10.5993/AJHB.43.1.8. ISSN 1087-3244. PMID 30522569. S2CID 54566712.
  56. 1 2 Farsalinos KE, Polosa R (2014). "Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review". Therapeutic Advances in Drug Safety. 5 (2): 67–86. doi:10.1177/2042098614524430. ISSN 2042-0986. PMC 4110871. PMID 25083263.
  57. ↑ Smith L, Brar K, Srinivasan K, Enja M, Lippmann S (June 2016). "E-cigarettes: How "safe" are they?". J Fam Pract. 65 (6): 380–385. PMID 27474819.
  58. ↑ Glover M, Breier BH, Bauld L (2016). "Could Vaping be a New Weapon in the Battle of the Bulge?". Nicotine & Tobacco Research. 19 (12): 1536–1540. doi:10.1093/ntr/ntw278. hdl:1893/26149. ISSN 1462-2203. PMID 27798086. S2CID 3799963.
  59. 1 2 Li L, Lin Y, Xia T, Zhu Y (7 January 2020). "Effects of Electronic Cigarettes on Indoor Air Quality and Health". Annual Review of Public Health. 41: 363–380. doi:10.1146/annurev-publhealth-040119-094043. ISSN 0163-7525. PMC 7346849. PMID 31910714.
  60. ↑ Detailed reference list is located at a separate image page.
  61. ↑ Cooke A, Fergeson J, Bulkhi A, Casale TB (2015). "The Electronic Cigarette: The Good, the Bad, and the Ugly". The Journal of Allergy and Clinical Immunology: In Practice. 3 (4): 498–505. doi:10.1016/j.jaip.2015.05.022. ISSN 2213-2198. PMID 26164573.
  62. ↑ Bertholon JF, Becquemin MH, Annesi-Maesano I, Dautzenberg B (2013). "Electronic cigarettes: a short review". Respiration; International Review of Thoracic Diseases. 86 (5): 433–438. doi:10.1159/000353253. PMID 24080743. S2CID 20521181.
  63. ↑ Jerry JM, Collins GB, Streem D (2015). "E-cigarettes: Safe to recommend to patients?". Cleve Clin J Med. 82 (8): 521–526. doi:10.3949/ccjm.82a.14054. PMID 26270431.
  64. ↑ Kundu A, Sachdeva K, Feore A, Sanchez S, Sutton M, Seth S, et al. (2025). "Evidence update on the cancer risk of vaping e-cigarettes: A systematic review". Tobacco Induced Diseases. 23: 1–14. doi:10.18332/tid/192934. PMC 11773639. PMID 39877383.
  65. ↑ "Johns Hopkins Finds Thousands of Unknown Chemicals in E-Cigarettes". Johns Hopkins University. Retrieved 24 November 2021.
  66. 1 2 3 4 5 6 7 8 9 Cheng T (May 2014). "Chemical evaluation of electronic cigarettes". Tobacco Control. 23 (Supplement 2): ii11–ii17. doi:10.1136/tobaccocontrol-2013-051482. PMC 3995255. PMID 24732157.
  67. ↑ Kim KH, Kabir E, Jahan SA (October 2016). "Review of electronic cigarettes as tobacco cigarette substitutes: Their potential human health impact". Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 34 (4): 262–275. Bibcode:2016JESHC..34..262K. doi:10.1080/10590501.2016.1236604. PMID 27635466. S2CID 42660975.
  68. ↑ Fernández E, Ballbè M, Sureda X, Fu M, Saltó E, Martínez-Sánchez JM (2015). "Particulate Matter from Electronic Cigarettes and Conventional Cigarettes: a Systematic Review and Observational Study". Current Environmental Health Reports. 2 (4): 423–429. Bibcode:2015CEHR....2..423F. doi:10.1007/s40572-015-0072-x. ISSN 2196-5412. PMID 26452675.
  69. ↑ Burstyn I (9 January 2014). "Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks". BMC Public Health. 14 (1) 18. doi:10.1186/1471-2458-14-18. ISSN 1471-2458. PMC 3937158. PMID 24406205.
  70. ↑ Kaisar MA, Prasad S, Liles T, Cucullo L (2016). "A Decade of e-Cigarettes: Limited Research & Unresolved Safety Concerns". Toxicology. 365: 67–75. Bibcode:2016Toxgy.365...67K. doi:10.1016/j.tox.2016.07.020. ISSN 0300-483X. PMC 4993660. PMID 27477296.
  71. 1 2 "Experts Clear the Air on E-Cigarettes". Columbia University Mailman School of Public Health. 26 January 2018.
  72. ↑ Jenssen BP, Boykan R (February 2019). "Electronic Cigarettes and Youth in the United States: A Call to Action (at the Local, National and Global Levels)". Children. 6 (2): 30. doi:10.3390/children6020030. PMC 6406299. PMID 30791645. This article incorporates text by Brian P. Jenssen and Rachel Boykan available under the CC BY 4.0 license.
  73. ↑ Kenny PJ (September 2014). "Genetics of Substance Use Disorders". Dialogues Clin Neurosci. 16 (3): 335–344. doi:10.31887/DCNS.2014.16.3/pkenny. PMC 4214176. PMID 25364284.
  74. ↑ D'Souza MS (2015). "Glutamatergic transmission in drug reward: implications for drug addiction". Frontiers in Neuroscience. 9: 404. doi:10.3389/fnins.2015.00404. ISSN 1662-453X. PMC 4633516. PMID 26594139.
  75. ↑ MacDonald K, Pappa K (April 2016). "WHY NOT POT?: A Review of the Brain-based Risks of Cannabis". Innov Clin Neurosci. 13 (3–4): 13–22. PMC 4911936. PMID 27354924.
  76. ↑ Kishioka S, Kiguchi N, Kobayashi Y, Saika F (2014). "Nicotine Effects and the Endogenous Opioid System". Journal of Pharmacological Sciences. 125 (2): 117–124. doi:10.1254/jphs.14R03CP. ISSN 1347-8613. PMID 24882143.
  77. ↑ Hiemstra PS, Bals R (2016). "Basic science of electronic cigarettes: assessment in cell culture and in vivo models". Respiratory Research. 17 (1): 127. doi:10.1186/s12931-016-0447-z. ISSN 1465-993X. PMC 5055681. PMID 27717371.
  78. ↑ Lee PN, Fariss MW (2016). "A systematic review of possible serious adverse health effects of nicotine replacement therapy". Archives of Toxicology. 91 (4): 1565–1594. doi:10.1007/s00204-016-1856-y. ISSN 0340-5761. PMC 5364244. PMID 27699443.
  79. ↑ D'Souza MS, Markou A (2011). "Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments". Addict Sci Clin Pract. 6 (1): 4–16. PMC 3188825. PMID 22003417.
  80. 1 2 Jackson K, Muldoon P, De Biasi M, Damaj M (2015). "New mechanisms and perspectives in nicotine withdrawal". Neuropharmacology. 96 (Pt B): 223–234. doi:10.1016/j.neuropharm.2014.11.009. ISSN 0028-3908. PMC 4444410. PMID 25433149.
  81. ↑ Hadjiconstantinou M, Neff NH (2011). "Nicotine and endogenous opioids: Neurochemical and pharmacological evidence". Neuropharmacology. 60 (7–8): 1209–1220. doi:10.1016/j.neuropharm.2010.11.010. ISSN 0028-3908. PMID 21108953. S2CID 45539554.
  82. 1 2 3 4 Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, et al. (2015). "Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse". Pharmacological Reviews. 67 (4): 872–1004. doi:10.1124/pr.115.010967. ISSN 1521-0081. PMID 26403687.
  83. ↑ Chenoweth MJ, Tyndale RF (2017). "Pharmacogenetic Optimization of Smoking Cessation Treatment". Trends in Pharmacological Sciences. 38 (1): 55–66. doi:10.1016/j.tips.2016.09.006. ISSN 0165-6147. PMC 5195866. PMID 27712845.
  84. ↑ Di Matteo V, Pierucci M, Di Giovanni G, Benigno A, Esposito E (2007). "The Neurobiological Bases for the Pharmacotherapy of Nicotine Addiction". Current Pharmaceutical Design. 13 (12): 1269–1284. doi:10.2174/138161207780618920. ISSN 1381-6128. PMID 17504235.
  85. 1 2 3 4 5 "Know The Risks: E-Cigarettes & Young People – Addiction". Surgeon General of the United States. 2016.Public Domain This article incorporates text from this source, which is in the public domain.
  86. ↑ Richard Beebe, Jeff Myers (19 July 2012). Professional Paramedic, Volume I: Foundations of Paramedic Care. Cengage Learning. pp. 640–. ISBN 978-1-133-71465-1.
  87. 1 2 3 Bullen C (2014). "Electronic Cigarettes for Smoking Cessation". Current Cardiology Reports. 16 (11) 538. doi:10.1007/s11886-014-0538-8. ISSN 1523-3782. PMID 25303892. S2CID 2550483.
  88. 1 2 3 4 Drug Therapeutics Bulletin (26 November 2014). "Republished: Nicotine and health". BMJ. 349. 2014.7.0264rep. doi:10.1136/bmj.2014.7.0264rep. ISSN 1756-1833. PMID 25428425. S2CID 45426626.
  89. ↑ Atta-ur-Rahman, Allen B. Reitz (1 January 2005). Frontiers in Medicinal Chemistry. Bentham Science Publishers. pp. 279–. ISBN 978-1-60805-205-9.
  90. ↑ Bruijnzeel AW (2012). "Tobacco addiction and the dysregulation of brain stress systems". Neuroscience & Biobehavioral Reviews. 36 (5): 1418–1441. doi:10.1016/j.neubiorev.2012.02.015. ISSN 0149-7634. PMC 3340450. PMID 22405889.
  91. ↑ Alasmari F, Al-Rejaie SS, AlSharari SD, Sari Y (2016). "Targeting glutamate homeostasis for potential treatment of nicotine dependence". Brain Research Bulletin. 121: 1–8. doi:10.1016/j.brainresbull.2015.11.010. ISSN 0361-9230. PMC 4783195. PMID 26589642.
  92. 1 2 Uchida S, Hotta H (2009). "Cerebral Cortical Vasodilatation Mediated by Nicotinic Cholinergic Receptors: Effects of Old Age and of Chronic Nicotine Exposure". Biological & Pharmaceutical Bulletin. 32 (3): 341–344. doi:10.1248/bpb.32.341. ISSN 0918-6158. PMID 19252275.
  93. ↑ Laura J. Martin, David Zieve, Isla Ogilvie (7 June 2016). "Nicotine and Tobacco". Medline Plus.
  94. ↑ Khoudigian S, Devji T, Lytvyn L, Campbell K, Hopkins R, O'Reilly D (29 January 2016). "The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis". International Journal of Public Health. 61 (2): 257–267. doi:10.1007/s00038-016-0786-z. ISSN 1661-8556. PMID 26825455. S2CID 22227035.
  95. 1 2 "Nicotine". National Institute on Drug Abuse. June 2007. Archived from the original on 11 June 2019. Retrieved 2 June 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  96. ↑ Shahab L, Brose LS, West R (2013). "Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems". CNS Drugs. 27 (12): 1007–1019. doi:10.1007/s40263-013-0116-4. ISSN 1172-7047. PMID 24114587. S2CID 207486096.
  97. ↑ McNeill A, Brose LS, Calder R, Bauld L, Robson D. "Evidence review of e-cigarettes and heated tobacco products 2018" (PDF). Public Health Englanddate=February 2018. UK. p. 12.
  98. ↑ "DrugFacts: Electronic Cigarettes (e-Cigarettes)". National Institute on Drug Abuse. September 2014.
  99. ↑ Evans SE, Hoffman AC (2014). "Electronic cigarettes: abuse liability, topography and subjective effects". Tobacco Control. 23 (Supplement 2): ii23–ii29. doi:10.1136/tobaccocontrol-2013-051489. ISSN 0964-4563. PMC 3995256. PMID 24732159.
  100. ↑ Orellana-Barrios MA, Payne D, Mulkey Z, Nugent K (2015). "Electronic cigarettes-a narrative review for clinicians". The American Journal of Medicine. 128 (7): 674–81. doi:10.1016/j.amjmed.2015.01.033. ISSN 0002-9343. PMID 25731134.
  101. ↑ "State Health Officer's Report on E-Cigarettes" (PDF). p. 5.
  102. ↑ Schraufnagel DE (March 2015). "Electronic Cigarettes: Vulnerability of Youth". Pediatric Allergy, Immunology, and Pulmonology. 28 (1): 2–6. doi:10.1089/ped.2015.0490. PMC 4359356. PMID 25830075.
  103. ↑ "Teens like different forms of tobacco and nicotine". American Cancer Society. Archived from the original on 20 September 2015.
  104. ↑ Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DM, et al. (2016). "Tobacco Use Among Middle and High School Students — United States, 2011–2015". MMWR. Morbidity and Mortality Weekly Report. 65 (14): 361–367. doi:10.15585/mmwr.mm6514a1. ISSN 0149-2195. PMID 27077789.
  105. 1 2 Durmowicz EL (2014). "The impact of electronic cigarettes on the paediatric population". Tobacco Control. 23 (Supplement 2): ii41–ii46. doi:10.1136/tobaccocontrol-2013-051468. ISSN 0964-4563. PMC 3995262. PMID 24732163.
  106. ↑ "First NHS vape clinic treating addicts as young as 11". Financial Times. 13 March 2025. Retrieved 13 March 2025.
  107. ↑ "Youth E-Cigarette Use Drops to Lowest Level in a Decade". FDA. 5 September 2024. Retrieved 25 June 2026.
  108. ↑ "FCA Policy briefing Electronic Nicotine Delivery Systems" (PDF). Framework Convention Alliance on Tobacco Control. 13–18 October 2014. Archived from the original (PDF) on 6 March 2016. Retrieved 2 March 2016.
  109. 1 2 McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P, McRobbie H (2014). "Electronic cigarettes for smoking cessation and reduction". The Cochrane Database of Systematic Reviews. 12 (12) CD010216. doi:10.1002/14651858.CD010216.pub2. hdl:2292/27824. PMID 25515689.
  110. ↑ World Health Organization (2019). "Offer help to quit tobacco use". WHO report on the global tobacco epidemic, 2019 (Report). World Health Organization. ISBN 978-92-4-151620-4.
  111. 1 2 Farber HJ, Conrado Pacheco Gallego M, Galiatsatos P, Folan P, Lamphere T, Pakhale S (1 April 2021). "Harms of Electronic Cigarettes: What the Healthcare Provider Needs to Know". Annals of the American Thoracic Society. 18 (4): 567–572. doi:10.1513/AnnalsATS.202009-1113CME. ISSN 2329-6933. PMID 33284731. S2CID 227948907.
  112. ↑ Royal College of Physicians. "Nicotine Without Smoke -- Tobacco Harm Reduction". p. 125. Retrieved 30 September 2020. Use of nicotine alone, in the doses used by smokers, represents little if any hazard to the user.
  113. ↑ "E-cigarettes: an emerging public health consensus". UK: Public Health England. 15 September 2015.
  114. 1 2 3 4 "Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products". Federal Register. 81 (90). United States Food and Drug Administration: 28974–29106. 10 May 2016.
  115. ↑ Pisinger C, Dagli E, Filippidis FT, Hedman L, Janson C, Loukides S, et al. (December 2019). "ERS and tobacco harm reduction". European Respiratory Journal. 54 (6): 1902009. doi:10.1183/13993003.02009-2019. hdl:10044/1/75851. PMID 31801824. S2CID 208642811.
  116. ↑ Gualano MR, Passi S, Bert F, La Torre G, Scaioli G, Siliquini R (September 2015). "Electronic cigarettes: assessing the efficacy and the adverse effects through a systematic review of published studies". Journal of Public Health. 37 (3): 488–497. doi:10.1093/pubmed/fdu055. ISSN 1741-3842. PMID 25108741.
  117. 1 2 3 "Heart and Stroke Foundation: E-cigarettes in Canada". Heart and Stroke Foundation. September 2014. Archived from the original on 6 October 2014.
  118. 1 2 "WHO Right to Call for E-Cigarette Regulation". World Lung Federation. 26 August 2014. Archived from the original on 30 March 2018.
  119. ↑ Bullen C, Knight-West O (August 2016). "E-cigarettes for the management of nicotine addiction". Substance Abuse and Rehabilitation. 7: 111–118. doi:10.2147/SAR.S94264. ISSN 1179-8467. PMC 4993405. PMID 27574480.
  120. 1 2 3 Hartmann-Boyce J, McRobbie H, Butler AR, Lindson N, Bullen C, Begh R, et al. (14 September 2021). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 9 (9) CD010216. doi:10.1002/14651858.CD010216.pub6. ISSN 1469-493X. PMC 8438601. PMID 34519354.
  121. 1 2 "Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS)" (PDF). World Health Organization. August 2016. pp. 1–11.
  122. ↑ Bals R, Boyd J, Esposito S, Foronjy R, Hiemstra P, Jiménez-Ruiz CA, et al. (February 2019). "Electronic cigarettes: a task force report from the European Respiratory Society". European Respiratory Journal. 53 (2): 1801151. doi:10.1183/13993003.01151-2018. ISSN 0903-1936. PMID 30464018. S2CID 53711734. The long-term effects of ECIG use are unknown, and there is therefore no evidence that ECIGs are safer than tobacco in the long term. Based on current knowledge, negative health effects cannot be ruled out.
  123. 1 2 "Outbreak of Lung Illness Associated with Using E-cigarette Products". Centers for Disease Control and Prevention. 6 September 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  124. ↑ Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E, et al. (2018). "Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies". European Respiratory Journal. 51 (5): 1800278. doi:10.1183/13993003.00278-2018. ISSN 0903-1936. PMID 29848575.
  125. ↑ "RACGP endorses vaping for cessation". Royal Australian College of General Practitioners. 28 January 2020.
  126. 1 2 3 "Smoking, vaping and tobacco". Health Canada. 27 June 2018.
  127. 1 2 "Smoking, vaping, HTP, NRT and snus in China". Global State of Tobacco Harm Reduction. Retrieved 9 July 2025.
  128. ↑ Wang Z, Xu X, Laestadius L, Wang Y (1 January 2025). "Understanding stakeholder responses to the electronic cigarette flavor ban in China: A news media analysis". Public Health. 238: 303–309. doi:10.1016/j.puhe.2024.12.003. ISSN 0033-3506. PMID 39721111.
  129. ↑ Deng H, Fang L, Zhang L, Wen S, Zhang S, Wang F, et al. (14 September 2024). "An observational study of the marketing practice of e-cigarette specialty stores in two large cities in China: Is there potential to normalize the use of e-cigarettes?". Tobacco Induced Diseases. 22 (September): 1–12. doi:10.18332/tid/191840. ISSN 1617-9625. PMC 11401606. PMID 39280934. Archived from the original on 18 June 2025. Retrieved 11 July 2025.
  130. ↑ Lin J, Ma C (26 September 2025). "The hidden threat of tobacco use among Chinese adolescents". Tobacco Induced Diseases. 23 (September): 1–2. doi:10.18332/tid/209425. ISSN 1617-9625. PMC 12465112. PMID 41019461.
  131. ↑ He C, Chongsuvivatwong V, Li Y, Chotipanvithayakul R (28 January 2026). "Navigating regulatory challenges: a cross-sectional survey of vaping and smoking behaviours among university students in Yunnan, China". BMC Public Health. 26 (1): 684. doi:10.1186/s12889-026-26401-9. ISSN 1471-2458. PMC 12922305. PMID 41606551.
  132. ↑ "Youth vaping declines for a 3rd year in Aotearoa's largest youth survey of its kind, smoking remains low". ASH NZ. Retrieved 25 June 2026.
  133. ↑ "ELECTRONIC NICOTINE AND NON-NICOTINE DELIVERY SYSTEMS: A BRIEF" (PDF).
  134. ↑ "Nicotine vaping in England: an evidence update including health risks and perceptions, 2022" (PDF).
  135. ↑ "Juul gets FDA's OK to keep selling tobacco and menthol e-cigarettes". AP News. 17 July 2025. Retrieved 7 April 2026.
  136. ↑ "FDA lets Juul market vapes in the U.S. three years after trying to ban them". The Washington Post. 17 July 2025. ISSN 0190-8286. Retrieved 7 April 2026.
  137. ↑ Harris PA (9 September 2019). "AMA urges public to avoid e-cigarette use amid lung illness outbreak". American Medical Association.
  138. ↑ "AMA warns against use of e-cigs in light of lung illness reports". Reuters. 9 September 2019. Retrieved 23 October 2026.
  139. ↑ Wimmer H (10 September 2019). "American Lung Association: Do Not Use E-Cigarettes". American Lung Association. Retrieved 11 September 2019.
  140. ↑ "AMA calls for total ban on all vaping products not approved by FDA". American Medical Association. 19 November 2019.
  141. 1 2 3 4 Smith L, Brar K, Srinivasan K, Enja M, Lippmann S (June 2016). "E-cigarettes: How "safe" are they?". The Journal of Family Practice. 65 (6): 380–385. PMID 27474819.
  142. ↑ "Is vaping harmful? | Vaping side effects | Cancer Research UK". www.cancerresearchuk.org. Retrieved 25 June 2026.
  143. ↑ Palazzolo DL (November 2013). "Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review". Frontiers in Public Health. 1 (56): 56. Bibcode:2013FrPH....1...56P. doi:10.3389/fpubh.2013.00056. PMC 3859972. PMID 24350225. This article incorporates text by Dominic L. Palazzolo available under the CC BY 3.0 license.
  144. ↑ Kalkhoran S, Glantz SA (February 2016). "E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis". The Lancet. Respiratory Medicine. 4 (2): 116–128. doi:10.1016/S2213-2600(15)00521-4. PMC 4752870. PMID 26776875.
  145. ↑ "Burden of Tobacco Use in the U.S." Centers for Disease Control and Prevention. 8 October 2024. Retrieved 25 June 2026.
  146. ↑ "Harms of Cigarette Smoking and Health Benefits of Quitting - NCI". www.cancer.gov. 21 December 2017. Retrieved 25 June 2026.
  147. ↑ "Tobacco". www.who.int. Retrieved 25 June 2026.
  148. ↑ CDC (28 May 2024). "Health Effects of Vaping". Smoking and Tobacco Use. Retrieved 3 January 2025.
  149. ↑ Banks E, Yazidjoglou A, Brown S, Nguyen M, Martin M, Beckwith K, et al. (2022). "Electronic cigarettes and health outcomes: systematic review of global evidence". ANU Research Publications- Open Research Repository. doi:10.25911/XV0F-6C42.
  150. ↑ Smith N (20 January 2016). "Headlines about e-cigarettes don't mean they're 'not safer than tobacco'". Cancer Research UK. Archived from the original on 14 February 2019. Retrieved 13 February 2019.
  151. 1 2 Schraufnagel DE (March 2015). "Electronic Cigarettes: Vulnerability of Youth". Pediatric Allergy, Immunology, and Pulmonology. 28 (1): 2–6. doi:10.1089/ped.2015.0490. PMC 4359356. PMID 25830075.
  152. 1 2 3 Nansseu JR, Bigna JJ (2016). "Electronic Cigarettes for Curbing the Tobacco-Induced Burden of Noncommunicable Diseases: Evidence Revisited with Emphasis on Challenges in Sub-Saharan Africa". Pulmonary Medicine. 2016 4894352. doi:10.1155/2016/4894352. PMC 5220510. PMID 28116156. This article incorporates text by Jobert Richie N. Nansseu and Jean Joel R. Bigna available under the CC BY 4.0 license.
  153. ↑ Jankowski M, Krzystanek M, Zejda JE, Majek P, Lubanski J, Lawson JA, et al. (June 2019). "E-Cigarettes are More Addictive than Traditional Cigarettes-A Study in Highly Educated Young People". International Journal of Environmental Research and Public Health. 16 (13): 2279. Bibcode:2019IJERP..16.2279J. doi:10.3390/ijerph16132279. PMC 6651627. PMID 31252671.
  154. 1 2 3 "Electronic Cigarettes – An Overview" (PDF). German Cancer Research Center. 2013. Archived from the original (PDF) on 3 March 2016. Retrieved 27 February 2015.
  155. ↑ Sanford Z, Goebel L (2014). "E-cigarettes: an up to date review and discussion of the controversy". The West Virginia Medical Journal. 110 (4): 10–15. PMID 25322582.
  156. ↑ Smith L, Brar K, Srinivasan K, Enja M, Lippmann S (June 2016). "E-cigarettes: How "safe" are they?". The Journal of Family Practice. 65 (6): 380–385. PMID 27474819.
  157. ↑ Hartmann-Boyce J, Lindson N, Butler AR, McRobbie H, Bullen C, Begh R, et al. (November 2022). "Electronic cigarettes for smoking cessation". The Cochrane Database of Systematic Reviews. 11 (11) CD010216. doi:10.1002/14651858.CD010216.pub7. PMC 9668543. PMID 36384212.
  158. ↑ "Promote e-cigarettes widely as substitute for smoking says new RCP report". www.rcp.ac.uk. 12 May 2016. Retrieved 15 January 2025.
  159. ↑ Katie Hunt (17 September 2019). "The US and UK see vaping very differently. Here's why". CNN.
  160. ↑ "E-cigarettes: regulations for consumer products". GOV.UK. 12 July 2022.
  161. ↑ "Public Health Consequences of E-Cigarettes" (PDF).
  162. 1 2 3 Ebbert JO, Agunwamba AA, Rutten LJ (January 2015). "Counseling patients on the use of electronic cigarettes". Mayo Clinic Proceedings. 90 (1): 128–134. doi:10.1016/j.mayocp.2014.11.004. PMID 25572196.
  163. 1 2 Yang L, Rudy SF, Cheng JM, Durmowicz EL (May 2014). "Electronic cigarettes: incorporating human factors engineering into risk assessments". Tobacco Control. 23 (Supplement 2): ii47–ii53. doi:10.1136/tobaccocontrol-2013-051479. PMC 3995290. PMID 24732164.
  164. 1 2 3 4 5 6 7 8 Rom O, Pecorelli A, Valacchi G, Reznick AZ (March 2015). "Are E-cigarettes a safe and good alternative to cigarette smoking?". Annals of the New York Academy of Sciences. 1340 (1): 65–74. Bibcode:2015NYASA1340...65R. doi:10.1111/nyas.12609. PMID 25557889. S2CID 26187171.
  165. 1 2 3 4 Kaisar MA, Prasad S, Liles T, Cucullo L (July 2016). "A decade of e-cigarettes: Limited research & unresolved safety concerns". Toxicology. 365: 67–75. Bibcode:2016Toxgy.365...67K. doi:10.1016/j.tox.2016.07.020. PMC 4993660. PMID 27477296.
  166. ↑ Khan MS, Khateeb F, Akhtar J, Khan Z, Lal A, Kholodovych V, et al. (March 2018). "Organizing pneumonia related to electronic cigarette use: A case report and review of literature". The Clinical Respiratory Journal. 12 (3): 1295–1299. doi:10.1111/crj.12775. PMID 29392888. S2CID 4316261.
  167. ↑ Lauterstein D, Hoshino R, Gordon T, Watkins BX, Weitzman M, Zelikoff J (2014). "The changing face of tobacco use among United States youth". Current Drug Abuse Reviews. 7 (1): 29–43. doi:10.2174/1874473707666141015220110. PMC 4469045. PMID 25323124.
  168. ↑ "Know the Risks". Surgeon General of the United States. 2016.Public Domain This article incorporates text from this source, which is in the public domain.
  169. 1 2 3 Paley GL, Echalier E, Eck TW, Hong AR, Farooq AV, Gregory DG, et al. (July 2016). "Corneoscleral Laceration and Ocular Burns Caused by Electronic Cigarette Explosions". Cornea. 35 (7): 1015–1018. doi:10.1097/ICO.0000000000000881. PMC 4900417. PMID 27191672.
  170. 1 2 3 Vaught B, Spellman J, Shah A, Stewart A, Mullin D (March 2017). "Facial trauma caused by electronic cigarette explosion". Ear, Nose, & Throat Journal. 96 (3): 139–142. doi:10.1177/014556131709600314. PMID 28346645.
  171. 1 2 3 4 5 6 7 8 9 10 11 12 Stratton K, Kwan LY, Eaton DL (January 2018). Stratton K, Kwan LY, Eaton DL (eds.). Public Health Consequences of E-Cigarettes (PDF). National Academies of Sciences, Engineering, and Medicine (National Academies Press). pp. 1–774. Bibcode:2018nap..book24952N. doi:10.17226/24952. ISBN 978-0-309-46834-3. PMID 29894118.
  172. ↑ Serror K, Chaouat M, Legrand MM, Depret F, Haddad J, Malca N, et al. (May 2018). "Burns caused by electronic vaping devices (e-cigarettes): A new classification proposal based on mechanisms". Burns. 44 (3): 544–548. doi:10.1016/j.burns.2017.09.005. PMID 29056367.
  173. 1 2 3 4 5 6 7 8 McNeill A, Brose LS, Calder R, Bauld L, Robson D (February 2018). "Evidence review of e-cigarettes and heated tobacco products 2018" (PDF). UK: Public Health England. pp. 1–243.
  174. ↑ Patterson SB, Beckett AR, Lintner A, Leahey C, Greer A, Brevard SB, et al. (2017). "A Novel Classification System for Injuries After Electronic Cigarette Explosions". Journal of Burn Care & Research. 38 (1): e95–e100. doi:10.1097/BCR.0000000000000471. PMID 27893577. S2CID 3433324.
  175. ↑ Makadia LD, Roper PJ, Andrews JO, Tingen MS (August 2017). "Tobacco Use and Smoke Exposure in Children: New Trends, Harm, and Strategies to Improve Health Outcomes". Current Allergy and Asthma Reports. 17 (8) 55. doi:10.1007/s11882-017-0723-0. PMID 28741144. S2CID 22360961.
  176. 1 2 Harshman J, Vojvodic M, Rogers AD (October 2018). "Burns associated with e-cigarette batteries: A case series and literature review". CJEM. 20 (S2): S20–S28. doi:10.1017/cem.2017.32. PMID 28566106.
  177. ↑ Hickey S, Goverman J, Friedstat J, Sheridan R, Schulz J (August 2018). "Thermal injuries from exploding electronic cigarettes". Burns. 44 (5): 1294–1301. doi:10.1016/j.burns.2018.02.008. PMID 29503045. S2CID 3709168.
  178. ↑ Arnaout A, Khashaba H, Dobbs T, Dewi F, Pope-Jones S, Sack A, et al. (June 2017). "The Southwest UK Burns Network (SWUK) experience of electronic cigarette explosions and review of literature". Burns. 43 (4): e1–e6. doi:10.1016/j.burns.2017.01.008. PMID 28412133.
  179. 1 2 3 4 "Electronic Cigarette Fires and Explosions in the United States 2009 – 2016" (PDF). United States Fire Administration. July 2017. pp. 1–56.Public Domain This article incorporates text from this source, which is in the public domain.
  180. ↑ Caplan D (22 December 2016). "Man Suffers 3rd-Degree Burns After E-Cigarette Explodes in His Pocket While Riding Bus". ABC News.
  181. ↑ Sheckter C, Chattopadhyay A, Paro J, Karanas Y (2016). "Burns resulting from spontaneous combustion of electronic cigarettes: a case series". Burns & Trauma. 4 (1) s41038-016-0061-9: 35. doi:10.1186/s41038-016-0061-9. PMC 5151131. PMID 27995151. This article incorporates text by Clifford Sheckter, Arhana Chattopadhyay, John Paro and Yvonne Karanas available under the CC BY 4.0 license.
  182. ↑ Detailed reference list is located at a separate image page.
  183. ↑ Jo CL, Ambs A, Dresler CM, Backinger CL (February 2017). "Child-resistant and tamper-resistant packaging: A systematic review to inform tobacco packaging regulation". Preventive Medicine. 95: 89–95. doi:10.1016/j.ypmed.2016.11.013. PMC 5299541. PMID 27939602.
  184. 1 2 3 4 5 Hua M, Talbot P (December 2016). "Potential health effects of electronic cigarettes: A systematic review of case reports". Preventive Medicine Reports. 4: 169–178. doi:10.1016/j.pmedr.2016.06.002. PMC 4929082. PMID 27413679. This article incorporates text available under the CC BY 4.0 license.
  185. 1 2 3 Biyani S, Derkay CS (August 2015). "E-cigarettes: Considerations for the otolaryngologist". International Journal of Pediatric Otorhinolaryngology. 79 (8): 1180–1183. doi:10.1016/j.ijporl.2015.04.032. PMID 25998217.
  186. 1 2 3 4 5 Kim KH, Kabir E, Jahan SA (October 2016). "Review of electronic cigarettes as tobacco cigarette substitutes: Their potential human health impact". Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 34 (4): 262–275. Bibcode:2016JESHC..34..262K. doi:10.1080/10590501.2016.1236604. PMID 27635466. S2CID 42660975.
  187. ↑ Gordon T, Karey E, Rebuli ME, Escobar YN, Jaspers I, Chen LC (6 January 2022). "E-Cigarette Toxicology". Annual Review of Pharmacology and Toxicology. 62: 301–322. doi:10.1146/annurev-pharmtox-042921-084202. ISSN 0362-1642. PMC 9386787. PMID 34555289.
  188. 1 2 3 4 Chatham-Stephens K, Law R, Taylor E, Kieszak S, Melstrom P, Bunnell R, et al. (December 2016). "Exposure Calls to U. S. Poison Centers Involving Electronic Cigarettes and Conventional Cigarettes-September 2010-December 2014". Journal of Medical Toxicology. 12 (4): 350–357. doi:10.1007/s13181-016-0563-7. PMC 5135675. PMID 27352081.
  189. ↑ Nelluri BK, Murphy K, Mookadam F (May 2015). "Electronic cigarettes and cardiovascular risk: hype or up in smoke?". Future Cardiology. 11 (3): 271–273. doi:10.2217/fca.15.13. PMID 26021631.
  190. ↑ Chatham-Stephens K (20 October 2014). "Young Children and e-Cigarette Poisoning". Medscape.
  191. 1 2 3 Govindarajan P, Spiller HA, Casavant MJ, Chounthirath T, Smith GA (May 2018). "E-Cigarette and Liquid Nicotine Exposures Among Young Children". Pediatrics. 141 (5) e20173361. doi:10.1542/peds.2017-3361. PMID 29686144.
  192. 1 2 3 "Some E-cigarette Users Are Having Seizures, Most Reports Involving Youth and Young Adults". United States Food and Drug Administration. 3 April 2019. Archived from the original on 3 April 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  193. ↑ Jenssen BP, Walley SC (February 2019). "E-Cigarettes and Similar Devices". Pediatrics. 143 (2) e20183652. doi:10.1542/peds.2018-3652. PMC 6644065. PMID 30835247.
  194. ↑ "New CDC study finds dramatic increase in e-cigarette-related calls to poison centers". Centers for Disease Control and Prevention. 3 April 2014.Public Domain This article incorporates text from this source, which is in the public domain.
  195. 1 2 Kamboj A, Spiller HA, Casavant MJ, Chounthirath T, Smith GA (June 2016). "Pediatric Exposure to E-Cigarettes, Nicotine, and Tobacco Products in the United States". Pediatrics. 137 (6) e20160041. doi:10.1542/peds.2016-0041. PMID 27244861.
  196. ↑ "E-Cigarettes and Liquid Nicotine". American Association of Poison Control Centers. 2018.
  197. 1 2 Peterson LA, Hecht SS (April 2017). "Tobacco, e-cigarettes, and child health". Current Opinion in Pediatrics. 29 (2): 225–230. doi:10.1097/MOP.0000000000000456. PMC 5598780. PMID 28059903.
  198. ↑ Xie W, Kathuria H, Galiatsatos P, Blaha MJ, Hamburg NM, Robertson RM, et al. (2 November 2020). "Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018". JAMA Network Open. 3 (11): e2020816. doi:10.1001/jamanetworkopen.2020.20816. ISSN 2574-3805. PMC 7662143. PMID 33180127.
  199. 1 2 3 4 5 Orellana-Barrios MA, Payne D, Mulkey Z, Nugent K (July 2015). "Electronic Cigarettes—A Narrative Review for Clinicians". The American Journal of Medicine. 128 (7): 674–681. doi:10.1016/j.amjmed.2015.01.033. PMID 25731134.
  200. 1 2 Wyman AE, Hines SE (April 2018). "Update on metal-induced occupational lung disease". Current Opinion in Allergy and Clinical Immunology. 18 (2): 73–79. doi:10.1097/ACI.0000000000000420. PMID 29337701. S2CID 3613573.
  201. 1 2 3 4 5 6 7 8 9 Cai H, Wang C (October 2017). "Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns". Redox Biology. 13: 402–406. doi:10.1016/j.redox.2017.05.013. PMC 5493817. PMID 28667909.
  202. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Qasim H, Karim ZA, Rivera JO, Khasawneh FT, Alshbool FZ (August 2017). "Impact of Electronic Cigarettes on the Cardiovascular System". Journal of the American Heart Association. 6 (9) e006353. doi:10.1161/JAHA.117.006353. PMC 5634286. PMID 28855171.
  203. 1 2 3 4 5 Shields PG, Berman M, Brasky TM, Freudenheim JL, Mathe E, McElroy JP, et al. (August 2017). "A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation". Cancer Epidemiology, Biomarkers & Prevention. 26 (8): 1175–1191. doi:10.1158/1055-9965.EPI-17-0358. PMC 5614602. PMID 28642230.
  204. ↑ Barraza LF, Weidenaar KE, Cook LT, Logue AR, Halpern MT (August 2017). "Regulations and policies regarding e-cigarettes". Cancer. 123 (16): 3007–3014. doi:10.1002/cncr.30725. PMID 28440949. S2CID 45269159.
  205. 1 2 3 4 5 6 7 8 9 10 Grana R, Benowitz N, Glantz SA (May 2014). "E-cigarettes: a scientific review". Circulation. 129 (19): 1972–1986. doi:10.1161/circulationaha.114.007667. PMC 4018182. PMID 24821826.
  206. 1 2 Collaco JM, Drummond MB, McGrath-Morrow SA (February 2015). "Electronic cigarette use and exposure in the pediatric population". JAMA Pediatrics. 169 (2): 177–182. doi:10.1001/jamapediatrics.2014.2898. PMC 5557497. PMID 25546699.
  207. 1 2 3 4 5 6 7 8 9 Glantz SA, Bareham DW (April 2018). "E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications". Annual Review of Public Health. 39 (1): 215–235. doi:10.1146/annurev-publhealth-040617-013757. PMC 6251310. PMID 29323609. This article incorporates text by Stanton A. Glantz and David W. Bareham available under the CC BY 4.0 license.
  208. 1 2 3 4 Benowitz NL, Fraiman JB (August 2017). "Cardiovascular effects of electronic cigarettes". Nature Reviews. Cardiology. 14 (8): 447–456. doi:10.1038/nrcardio.2017.36. PMC 5519136. PMID 28332500.
  209. ↑ Henry TS, Kligerman SJ, Raptis CA, Mann H, Sechrist JW, Kanne JP (March 2020). "Imaging Findings of Vaping-Associated Lung Injury". AJR. American Journal of Roentgenology. 214 (3): 498–505. doi:10.2214/AJR.19.22251. PMID 31593518. S2CID 203985885.
  210. 1 2 3 4 5 6 Singh J, Luquet E, Smith DP, Potgieter HJ, Ragazzon P (December 2016). "Toxicological and analytical assessment of e-cigarette refill components on airway epithelia" (PDF). Science Progress. 99 (4): 351–398. doi:10.3184/003685016X14773090197706. PMC 10365464. PMID 28742478. S2CID 4573125.
  211. ↑ Gualano MR, Passi S, Bert F, La Torre G, Scaioli G, Siliquini R (September 2015). "Electronic cigarettes: assessing the efficacy and the adverse effects through a systematic review of published studies". Journal of Public Health. 37 (3): 488–497. doi:10.1093/pubmed/fdu055. PMID 25108741.
  212. ↑ Greenhill R, Dawkins L, Notley C, Finn MD, Turner JJ (December 2016). "Adolescent Awareness and Use of Electronic Cigarettes: A Review of Emerging Trends and Findings". The Journal of Adolescent Health. 59 (6): 612–619. doi:10.1016/j.jadohealth.2016.08.005. PMID 27693128.
  213. ↑ Lødrup Carlsen KC, Skjerven HO, Carlsen KH (September 2018). "The toxicity of E-cigarettes and children's respiratory health". Paediatric Respiratory Reviews. 28: 63–67. doi:10.1016/j.prrv.2018.01.002. PMID 29580719. S2CID 4368058.
  214. ↑ Brose LS, Reid JL, Robson D, McNeill A, Hammond D (29 May 2024). "Associations between vaping and self-reported respiratory symptoms in young people in Canada, England and the US". BMC Medicine. 22 (1): 213. doi:10.1186/s12916-024-03428-6. ISSN 1741-7015. PMC 11134717. PMID 38807205.
  215. ↑ "Vaping is linked with breathing issues in young people". NIHR Evidence. 11 March 2025.
  216. ↑ Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. (5 March 2020). "Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin — Final Report". New England Journal of Medicine. 382 (10): 903–916. doi:10.1056/NEJMoa1911614. ISSN 0028-4793. PMID 31491072.{{cite journal}}: CS1 maint: overridden setting (link)
  217. 1 2 3 4 "Outbreak of Lung Injury Associated with E-Cigarette Use, or Vaping". Centers for Disease Control and Prevention. 28 January 2020.Public Domain This article incorporates text from this source, which is in the public domain.
  218. ↑ Kelland K (14 October 2019). "Vaping illness, deaths likely very rare beyond U.S., experts say". Reuters.
  219. 1 2 "New CDC Report Provides First Analysis of Lung Injury Deaths Associated with Use of E-cigarette, or Vaping, Products | CDC". www.cdc.gov. 28 October 2019. Retrieved 19 June 2020.
  220. ↑ "E-cigarette, or Vaping, Associated Lung Injury (EVALI) California Brief Update". cdph.ca.gov. 4 January 2022. Retrieved 3 June 2022.
  221. ↑ Klenske N (10 March 2022). "Differentiating EVALI from COVID-19 on Imaging Proves Challenging". Radiological Society of North America. Retrieved 1 August 2022.
  222. ↑ Blagev DP, Callahan SJ, Harris D, Collingridge DS, Hopkins RO, Eve JR, et al. (9 May 2022). "Prospectively Assessed Long-Term Outcomes of Patients with E-cigarette or Vaping-associated Lung Injury (EVALI)". Annals of the American Thoracic Society. 19 (11): AnnalsATS.202201–049OC. doi:10.1513/AnnalsATS.202201-049OC. PMC 9667811. PMID 35533314. S2CID 248669259.
  223. ↑ "Transcript of September 6, 2019, Telebriefing: Investigation of Pulmonary Disease Among People Who Use E-cigarettes". Centers for Disease Control and Prevention. 6 September 2019.Public Domain This article incorporates text from this source, which is in the public domain.
  224. ↑ King BA, Jones CM, Baldwin GT, Briss PA (2020). "The EVALI and Vaping Epidemics — Implications for Public Health". New England Journal of Medicine. 382 (8): 689–691. doi:10.1056/NEJMp1916171. ISSN 0028-4793. PMC 7122126. PMID 31951683.
  225. ↑ Darabseh MZ, Selfe J, Morse CI, Degens H (January 2020). "Is vaping better than smoking for cardiorespiratory and muscle function?". Multidisciplinary Respiratory Medicine. 15 (1): 674. doi:10.4081/mrm.2020.674. PMC 7348661. PMID 32670575.
  226. ↑ Münzel T, Hahad O, Kuntic M, Keaney JF, Deanfield JE, Daiber A (November 2020). "Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes". European Heart Journal. 41 (41): 4057–4070. doi:10.1093/eurheartj/ehaa460. PMC 7454514. PMID 32585699.
  227. ↑ Siddiqi TJ, Rashid AM, Siddiqi AK, Anwer A, Usman MS, Sakhi H, et al. (September 2023). "Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis". Current Problems in Cardiology. 48 (9) 101748. doi:10.1016/j.cpcardiol.2023.101748. PMID 37088177.
  228. ↑ Zong H, Hu Z, Li W (20 February 2024). "Electronic cigarettes and cardiovascular disease: epidemiological and biological links". European Journal of Physiology. 476 (6): 875–888. doi:10.1007/s00424-024-02925-0. PMC 11139732. PMID 38376568.
  229. ↑ Skotsimara G, Antonopoulos AS, Oikonomou E, Siasos G, Ioakeimidis N, Tsalamandris S, et al. (July 2019). "Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis". European Journal of Preventive Cardiology. 26 (11): 1219–1228. doi:10.1177/2047487319832975. PMID 30823865. S2CID 73506976.
  230. ↑ Knura M, Dragon J, Łabuzek K, Okopień B (January 2018). "The impact of electronic cigarettes usage on the endothelial function and the progression of atherosclerosis". Polski Merkuriusz Lekarski. 44 (259): 26–30. PMID 29374420.
  231. 1 2 Nelluri B, Murphy K, Mookadam F, Mookadam M (March 2016). "The current literature regarding the cardiovascular effects of electronic cigarettes". Future Cardiology. 12 (2): 167–179. doi:10.2217/fca.15.83. PMID 26916427.
  232. ↑ Turner JR (November 2009). "Intestinal mucosal barrier function in health and disease". Nature Reviews Immunology. 9 (11): 799–809. doi:10.1038/nri2653. ISSN 1474-1741. PMID 19855405.
  233. 1 2 Oshima T, Miwa H (August 2016). "Gastrointestinal mucosal barrier function and diseases". Journal of Gastroenterology. 51 (8): 768–778. doi:10.1007/s00535-016-1207-z. ISSN 1435-5922. PMID 27048502.
  234. 1 2 Sharma A, Lee J, Fonseca AG, Moshensky A, Kothari T, Sayed IM, et al. (6 January 2021). "E-cigarettes compromise the gut barrier and trigger inflammation". iScience. 24 (2) 102035. Bibcode:2021iSci...24j2035S. doi:10.1016/j.isci.2021.102035. ISSN 2589-0042. PMC 7841355. PMID 33537654.
  235. ↑ Sharma A, Lee J, Fonseca A, Crotty-Alexander L, Ghosh P (19 February 2021). "E-cigarettes compromise the gut barrier and trigger inflammation". iScience. 24 (2) 102035. Bibcode:2021iSci...24j2035S. doi:10.1016/j.isci.2021.102035. PMC 7841355. PMID 33537654.
  236. ↑ Debnath M, Debnath D, Singh P, Wert Y, Nookala V (24 July 2022). "Effect of Electronic Cigarettes on the Gastrointestinal System". Cureus. 14 (7) e27210. doi:10.7759/cureus.27210. ISSN 2168-8184. PMC 9322142. PMID 35903484.
  237. ↑ López-Ojeda W, Hurley RA (January 2024). "Vaping and the Brain: Effects of Electronic Cigarettes and E-Liquid Substances". The Journal of Neuropsychiatry and Clinical Neurosciences. 36 (1): A5–5. doi:10.1176/appi.neuropsych.20230184. ISSN 0895-0172. PMID 38226910.
  238. ↑ Heldt NA, Seliga A, Winfield M, Gajghate S, Reichenbach N, Yu X, et al. (August 2020). "Electronic cigarette exposure disrupts blood-brain barrier integrity and promotes neuroinflammation". Brain, Behavior, and Immunity. 88: 363–380. doi:10.1016/j.bbi.2020.03.034. ISSN 1090-2139. PMC 7899242. PMID 32243899.
  239. 1 2 Javed F, Kellesarian SV, Sundar IK, Romanos GE, Rahman I (November 2017). "Recent updates on electronic cigarette aerosol and inhaled nicotine effects on periodontal and pulmonary tissues". Oral Diseases. 23 (8): 1052–1057. doi:10.1111/odi.12652. PMC 5545167. PMID 28168771.
  240. ↑ Chaffee BW, Couch ET, Ryder MI (June 2016). "The tobacco-using periodontal patient: role of the dental practitioner in tobacco cessation and periodontal disease management". Periodontology 2000. 71 (1): 52–64. doi:10.1111/prd.12120. PMC 4842013. PMID 27045430.
  241. 1 2 Sultan AS, Jessri M, Farah CS (March 2021). "Electronic nicotine delivery systems: Oral health implications and oral cancer risk". Journal of Oral Pathology & Medicine. 50 (3): 316–322. doi:10.1111/jop.12810. PMID 30507043. S2CID 54527046.
  242. ↑ Visconti MJ, Ashack KA (October 2019). "Dermatologic manifestations associated with electronic cigarette use". Journal of the American Academy of Dermatology. 81 (4): 1001–1007. doi:10.1016/j.jaad.2019.03.088. PMID 30965061. S2CID 106409405.
  243. 1 2 3 Franck C, Filion KB, Kimmelman J, Grad R, Eisenberg MJ (May 2016). "Ethical considerations of e-cigarette use for tobacco harm reduction". Respiratory Research. 17 (1) 53. doi:10.1186/s12931-016-0370-3. PMC 4869264. PMID 27184265. This article incorporates text by Caroline Franck, Kristian B. Filion, Jonathan Kimmelman, Roland Grad and Mark J. Eisenberg available under the CC BY 4.0 license.
  244. 1 2 3 Wilder N, Daley C, Sugarman J, Partridge J (April 2016). "Nicotine without smoke: Tobacco harm reduction". UK: Royal College of Physicians. pp. 1–191.
  245. 1 2 Lippi G, Favaloro EJ, Meschi T, Mattiuzzi C, Borghi L, Cervellin G (February 2014). "E-cigarettes and cardiovascular risk: beyond science and mysticism". Seminars in Thrombosis and Hemostasis. 40 (1): 60–65. doi:10.1055/s-0033-1363468. PMID 24343348.
  246. 1 2 3 4 5 6 7 8 9 10 Bertholon JF, Becquemin MH, Annesi-Maesano I, Dautzenberg B (2013). "Electronic cigarettes: a short review". Respiration; International Review of Thoracic Diseases. 86 (5): 433–438. doi:10.1159/000353253. PMID 24080743. S2CID 20521181.
  247. 1 2 Drummond MB, Upson D (February 2014). "Electronic cigarettes. Potential harms and benefits". Annals of the American Thoracic Society. 11 (2): 236–242. doi:10.1513/annalsats.201311-391fr. PMC 5469426. PMID 24575993.
  248. ↑ Neuberger M (May 2015). "The electronic cigarette: a wolf in sheep's clothing". Wiener Klinische Wochenschrift. 127 (9–10): 385–387. doi:10.1007/s00508-015-0753-3. PMID 26230008. S2CID 10172525.
  249. ↑ Hess IM, Lachireddy K, Capon A (April 2016). "A systematic review of the health risks from passive exposure to electronic cigarette vapour". Public Health Research & Practice. 26 (2) e2621617. doi:10.17061/phrp2621617. PMID 27734060.
  250. 1 2 "E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General" (PDF). Surgeon General of the United States. 2016. pp. 1–298.Public Domain This article incorporates text from this source, which is in the public domain.
  251. ↑ Breland A, Soule E, Lopez A, Ramôa C, El-Hellani A, Eissenberg T (April 2017). "Electronic cigarettes: what are they and what do they do?". Annals of the New York Academy of Sciences. 1394 (1): 5–30. Bibcode:2017NYASA1394....5B. doi:10.1111/nyas.12977. PMC 4947026. PMID 26774031.
  252. ↑ Zainol Abidin N, Zainal Abidin E, Zulkifli A, Karuppiah K, Syed Ismail SN, Amer Nordin AS (September 2017). "Electronic cigarettes and indoor air quality: a review of studies using human volunteers" (PDF). Reviews on Environmental Health. 32 (3): 235–244. Bibcode:2017RvEH...32..235Z. doi:10.1515/reveh-2016-0059. PMID 28107173. S2CID 6885414.
  253. ↑ Collaco JM, McGrath-Morrow SA (April 2018). "Electronic Cigarettes: Exposure and Use Among Pediatric Populations". Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31 (2): 71–77. doi:10.1089/jamp.2017.1418. PMC 5915214. PMID 29068754.
  254. ↑ "Surgeon General Reports Youth and Young Adult E-Cigarette Use Poses a Public Health Threat". United States Department of Health and Human Services. 8 December 2016. Archived from the original on 28 January 2017. Retrieved 13 March 2021.Public Domain This article incorporates text from this source, which is in the public domain.
  255. ↑ "e-Cigarettes: a safe way to quit?". NPS MedicineWise. 11 June 2014. Archived from the original on 19 March 2017.
  256. ↑ Bam TS, Bellew W, Berezhnova I, Jackson-Morris A, Jones A, Latif E, et al. (January 2014). "Position statement on electronic cigarettes or electronic nicotine delivery systems". The International Journal of Tuberculosis and Lung Disease. 18 (1): 5–7. doi:10.5588/ijtld.13.0815. PMID 24365545. S2CID 26481455.
  257. ↑ "White Paper: Electronic Cigarettes in the Indoor Environment" (PDF). American Industrial Hygiene Association. 19 October 2014. Archived from the original (PDF) on 25 January 2017. Retrieved 18 August 2016.
  258. ↑ Dautzenberg B, Adler M, Garelik D, Loubrieu JF, Mathern G, Peiffer G, et al. (February 2017). "Practical guidelines on e-cigarettes for practitioners and others health professionals. A French 2016 expert's statement". Revue des Maladies Respiratoires. 34 (2): 155–164. doi:10.1016/j.rmr.2017.01.001. PMID 28189437.
  259. 1 2 "Electronic nicotine delivery systems" (PDF). World Health Organization. 21 July 2014. pp. 1–13.
  260. 1 2 "Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS)" (PDF). World Health Organization WHO. August 2016. pp. 1–11.
  261. 1 2 Kaur J, Rinkoo AV (September 2017). "Getting real with the upcoming challenge of electronic nicotine delivery systems: The way forward for the South-East Asia region". Indian Journal of Public Health. 61 (Suppl 1): S7–S11. doi:10.4103/ijph.IJPH_240_17. PMID 28928312.
  262. ↑ "State Health Officer's Report on E-Cigarettes: A Community Health Threat" (PDF). California Tobacco Control Program (California Department of Public Health). January 2015. pp. 1–21.Public Domain This article incorporates text from this source, which is in the public domain.
  263. 1 2 3 4 5 6 7 Clapp PW, Jaspers I (October 2017). "Electronic Cigarettes: Their Constituents and Potential Links to Asthma". Current Allergy and Asthma Reports. 17 (11) 79. doi:10.1007/s11882-017-0747-5. PMC 5995565. PMID 28983782.
  264. 1 2 Burstyn I (January 2014). "Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks". BMC Public Health. 14 (1) 18. doi:10.1186/1471-2458-14-18. PMC 3937158. PMID 24406205.
  265. 1 2 3 McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H (August 2015). "E-cigarettes: an evidence update" (PDF). UK: Public Health England. pp. 1–113.
  266. ↑ Meo SA, Al Asiri SA (2014). "Effects of electronic cigarette smoking on human health" (PDF). European Review for Medical and Pharmacological Sciences. 18 (21): 3315–3319. PMID 25487945.
  267. ↑ Biyani S, Derkay CS (March 2017). "E-cigarettes: An update on considerations for the otolaryngologist". International Journal of Pediatric Otorhinolaryngology. 94: 14–16. doi:10.1016/j.ijporl.2016.12.027. PMID 28167004.
  268. ↑ Frey LT, Tilburg WC (February 2016). "Child-Resistant Packaging for E-Liquid: A Review of US State Legislation". American Journal of Public Health. 106 (2): 266–268. doi:10.2105/AJPH.2015.302957. PMC 4815607. PMID 26691114.
  269. 1 2 3 Jimenez Ruiz CA, Solano Reina S, de Granda Orive JI, Signes-Costa Minaya J, de Higes Martinez E, Riesco Miranda JA, et al. (August 2014). "The electronic cigarette. Official statement of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on the efficacy, safety and regulation of electronic cigarettes". Archivos de Bronconeumologia. 50 (8): 362–367. doi:10.1016/j.arbres.2014.02.006. PMID 24684764.
  270. 1 2 Dagaonkar RS, Udwadi ZF (April 2014). "Water pipes and E-cigarettes: new faces of an ancient enemy" (PDF). The Journal of the Association of Physicians of India. 62 (4): 324–328. PMID 25327035. Archived from the original (PDF) on 4 March 2016. Retrieved 25 February 2015.
  271. ↑ Mayer B (January 2014). "How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century". Archives of Toxicology. 88 (1): 5–7. Bibcode:2014ArTox..88....5M. doi:10.1007/s00204-013-1127-0. PMC 3880486. PMID 24091634.
  272. ↑ England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA (August 2015). "Nicotine and the Developing Human: A Neglected Element in the Electronic Cigarette Debate". American Journal of Preventive Medicine. 49 (2): 286–293. doi:10.1016/j.amepre.2015.01.015. PMC 4594223. PMID 25794473.
  273. ↑ Brown CJ, Cheng JM (May 2014). "Electronic cigarettes: product characterisation and design considerations". Tobacco Control. 23 (Supplement 2): ii4–i10. doi:10.1136/tobaccocontrol-2013-051476. PMC 3995271. PMID 24732162.
  274. 1 2 Pepper JK, Brewer NT (September 2014). "Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review". Tobacco Control. 23 (5): 375–384. doi:10.1136/tobaccocontrol-2013-051122. PMC 4520227. PMID 24259045.
  275. ↑ Modesto-Lowe V, Alvarado C (September 2017). "E-cigs . . . Are They Cool? Talking to Teens About E-Cigarettes". Clinical Pediatrics. 56 (10): 947–952. doi:10.1177/0009922817705188. PMID 28443340. S2CID 44423931.
  276. ↑ "Do You Vape? See These Tips on How to Keep E-Liquids Away from Children". United States Food and Drug Administration. 2 May 2018. Archived from the original on 1 May 2018.Public Domain This article incorporates text from this source, which is in the public domain.
  277. ↑ "E-Cigarette Poisonings Among Toddlers Skyrocketed 1500% Over 3 Years". Yahoo! News. 9 May 2016.
  278. ↑ Boudi FB, Patel S, Boudi A, Chan C (December 2019). "Vitamin E Acetate as a Plausible Cause of Acute Vaping-related Illness". Cureus. 11 (12) e6350. doi:10.7759/cureus.6350. PMC 6952050. PMID 31938636. This article incorporates text by F Brian Boudi, Sonia Patel, Ava Boudi, Connie Chan available under the CC BY 3.0 license.
  279. 1 2 3 Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, et al. (October 2014). "Electronic cigarettes: a policy statement from the American Heart Association". Circulation. 130 (16): 1418–1436. Bibcode:2014Circu.130.1418B. doi:10.1161/CIR.0000000000000107. PMC 7643636. PMID 25156991.
  280. 1 2 "Be Smoke-free and Help Your Pets Live Longer, Healthier Lives - Electronic Nicotine Delivery Systems". United States Food and Drug Administration. 19 October 2017.Public Domain This article incorporates text from this source, which is in the public domain.
  281. ↑ https://www.poisoncontrol.org/home/ Texas Poison Control Network
  282. ↑ "Cancer Research UK Briefing: Electronic Cigarettes" (PDF). Cancer Research UK. May 2014.
  283. ↑ Orr MS (May 2014). "Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future". Tobacco Control. 23 (Supplement 2): ii18–ii22. doi:10.1136/tobaccocontrol-2013-051474. PMC 3995288. PMID 24732158.
  284. ↑ Rahman MA, Hann N, Wilson A, Worrall-Carter L (2014). "Electronic cigarettes: patterns of use, health effects, use in smoking cessation and regulatory issues". Tobacco Induced Diseases. 12 (1): 21. doi:10.1186/1617-9625-12-21. PMC 4350653. PMID 25745382.
  285. ↑ Xu Y, Guo Y, Liu K, Liu Z, Wang X (2016). "E-Cigarette Awareness, Use, and Harm Perception among Adults: A Meta-Analysis of Observational Studies". PLOS ONE. 11 (11) e0165938. Bibcode:2016PLoSO..1165938X. doi:10.1371/journal.pone.0165938. PMC 5115669. PMID 27861501.
  286. 1 2 3 4 5 Cooke A, Fergeson J, Bulkhi A, Casale TB (2015). "The Electronic Cigarette: The Good, the Bad, and the Ugly". The Journal of Allergy and Clinical Immunology. In Practice. 3 (4): 498–505. doi:10.1016/j.jaip.2015.05.022. PMID 26164573.
  287. 1 2 3 4 Sanner T, Grimsrud TK (2015). "Nicotine: Carcinogenicity and Effects on Response to Cancer Treatment - A Review". Frontiers in Oncology. 5: 196. doi:10.3389/fonc.2015.00196. PMC 4553893. PMID 26380225. This article incorporates text available under the CC BY 4.0 license.
  288. ↑ Knorst MM, Benedetto IG, Hoffmeister MC, Gazzana MB (October 2014). "The electronic cigarette: the new cigarette of the 21st century?". Jornal Brasileiro de Pneumologia. 40 (5): 564–572. doi:10.1590/S1806-37132014000500013. PMC 4263338. PMID 25410845.
  289. 1 2 Hiemstra PS, Bals R (October 2016). "Basic science of electronic cigarettes: assessment in cell culture and in vivo models". Respiratory Research. 17 (1) 127. doi:10.1186/s12931-016-0447-z. PMC 5055681. PMID 27717371. This article incorporates text available under the CC BY 4.0 license.
  290. ↑ Arnold C (September 2014). "Vaping and health: what do we know about e-cigarettes?". Environmental Health Perspectives. 122 (9): A244–A249. Bibcode:2014EnvHP.122.A244A. doi:10.1289/ehp.122-A244. PMC 4154203. PMID 25181730.Public Domain This article incorporates text from this source, which is in the public domain.
  291. ↑ Alawsi F, Nour R, Prabhu S (August 2015). "Are e-cigarettes a gateway to smoking or a pathway to quitting?". British Dental Journal. 219 (3): 111–115. doi:10.1038/sj.bdj.2015.591. PMID 26271862. S2CID 24120636.
  292. ↑ Oh AY, Kacker A (December 2014). "Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes? Review on E-cigarette vapor versus tobacco smoke". The Laryngoscope. 124 (12): 2702–2706. doi:10.1002/lary.24750. PMID 25302452. S2CID 10560264.
  293. ↑ Papaefstathiou E, Stylianou M, Agapiou A (May 2019). "Main and side stream effects of electronic cigarettes". Journal of Environmental Management. 238: 10–17. Bibcode:2019JEnvM.238...10P. doi:10.1016/j.jenvman.2019.01.030. PMID 30836280. S2CID 73462201.
  294. ↑ "Known and Probable Human Carcinogens". www.cancer.org.
  295. 1 2 3 4 5 6 Bekki K, Uchiyama S, Ohta K, Inaba Y, Nakagome H, Kunugita N (October 2014). "Carbonyl compounds generated from electronic cigarettes". International Journal of Environmental Research and Public Health. 11 (11): 11192–11200. Bibcode:2014IJERP..1111192B. doi:10.3390/ijerph111111192. PMC 4245608. PMID 25353061.
  296. 1 2 3 4 5 6 7 8 Rowell TR, Tarran R (December 2015). "Will chronic e-cigarette use cause lung disease?". American Journal of Physiology. Lung Cellular and Molecular Physiology. 309 (12): L1398–L1409. doi:10.1152/ajplung.00272.2015. PMC 4683316. PMID 26408554.
  297. ↑ Spurrier-Best L, Butcher D, Evangelene Blackham-Hayward E, Kertesz Z, Chichger H (22 January 2026). "Nicotine-free electronic vape fluid stimulates angiogenic processes in vitro through ARF6-mediated oxidative stress". Frontiers in Toxicology. 7, 2025 1699112. doi:10.3389/ftox.2025.1699112. PMC 12872546. PMID 41659018.
  298. ↑ Blackham-Hayward E, Kertesz Z, Chichger H (14 January 2024). "Electronic vape fluid activates the pulmonary endothelium and disrupts vascular integrity in vitro through an ARF6-dependent pathway". Microvascular Research. 153 (104653) 104653. doi:10.1016/j.mvr.2024.104653. ISSN 0026-2862. PMID 38220030. Retrieved 22 January 2026 – via Elsevier Science Direct.
  299. 1 2 3 Schick SF, Blount BC, Jacob P, Saliba NA, Bernert JT, El Hellani A, et al. (September 2017). "Biomarkers of exposure to new and emerging tobacco delivery products". American Journal of Physiology. Lung Cellular and Molecular Physiology. 313 (3): L425–L452. doi:10.1152/ajplung.00343.2016. PMC 5626373. PMID 28522563.
  300. 1 2 3 4 Ramôa CP, Eissenberg T, Sahingur SE (October 2017). "Increasing popularity of waterpipe tobacco smoking and electronic cigarette use: Implications for oral healthcare". Journal of Periodontal Research. 52 (5): 813–823. doi:10.1111/jre.12458. PMC 5585021. PMID 28393367.
  301. 1 2 3 4 Wolff MS, Buckley JP, Engel SM, McConnell RS, Barr DB (April 2017). "Emerging exposures of developmental toxicants". Current Opinion in Pediatrics. 29 (2): 218–224. doi:10.1097/MOP.0000000000000455. PMC 5473289. PMID 28059904.
  302. 1 2 Zare S, Nemati M, Zheng Y (2018). "A systematic review of consumer preference for e-cigarette attributes: Flavor, nicotine strength, and type". PLOS ONE. 13 (3) e0194145. Bibcode:2018PLoSO..1394145Z. doi:10.1371/journal.pone.0194145. PMC 5854347. PMID 29543907. This article incorporates text available under the CC BY 4.0 license.
  303. 1 2 Jankowski M, Brożek G, Lawson J, Skoczyński S, Zejda JE (May 2017). "E-smoking: Emerging public health problem?". International Journal of Occupational Medicine and Environmental Health. 30 (3): 329–344. doi:10.13075/ijomeh.1896.01046. PMID 28481369.
  304. 1 2 Bonilla A, Blair AJ, Alamro SM, Ward RA, Feldman MB, Dutko RA, et al. (September 2019). "Recurrent spontaneous pneumothoraces and vaping in an 18-year-old man: a case report and review of the literature". Journal of Medical Case Reports. 13 (1) 283. doi:10.1186/s13256-019-2215-4. PMC 6732835. PMID 31495337. This article incorporates text available under the CC BY 4.0 license.
  305. ↑ Bhatnagar A (June 2016). "Cardiovascular Perspective of the Promises and Perils of E-Cigarettes". Circulation Research. 118 (12): 1872–1875. doi:10.1161/CIRCRESAHA.116.308723. PMC 5505630. PMID 27283531.
  306. ↑ "Vaping myths and facts - Better Health". nhs.uk. 13 September 2023. Retrieved 19 August 2026.
  307. ↑ Dhand R (July 2017). "Inhaled Drug Therapy 2016: The Year in Review". Respiratory Care. 62 (7): 978–996. doi:10.4187/respcare.05624. PMID 28559466.
  308. ↑ Huang SJ, Xu YM, Lau AT (June 2018). "Electronic cigarette: A recent update of its toxic effects on humans". Journal of Cellular Physiology. 233 (6): 4466–4478. doi:10.1002/jcp.26352. PMID 29215738. S2CID 3556795.
  309. ↑ Zborovskaya Y (February 2017). "E-Cigarettes and Smoking Cessation: A Primer for Oncology Clinicians". Clinical Journal of Oncology Nursing. 21 (1): 54–63. doi:10.1188/17.CJON.54-63. PMID 28107337. S2CID 206992720.
  310. ↑ Detailed reference list is located on a separate image page.
  311. ↑ Vij K (2014). Textbook of Forensic Medicine & Toxicology: Principles & Practice (5th ed.). Elsevier Health Sciences. p. 525. ISBN 978-81-312-3623-9. Extract of page 525
  312. ↑ "NICOTINE: Systemic Agent". 8 July 2021.
  313. ↑ "Nicotine". Dictionary of Toxicology. Singapore: Springer Nature. 2024. p. 691. doi:10.1007/978-981-99-9283-6_1860. ISBN 978-981-99-9282-9. Retrieved 19 October 2024. Nicotine is a colorless, water-soluble, and extremely hazardous alkaloid. It also has a terrible taste.
  314. ↑ CDC (31 January 2025). "Health Effects of Vaping". Smoking and Tobacco Use. Retrieved 17 September 2025.
  315. ↑ Royal College of Physicians. "Nicotine Without Smoke -- Tobacco Harm Reduction". p. 125. Archived from the original on 1 November 2020. Retrieved 30 September 2020. Use of nicotine alone, in the doses used by smokers, represents little if any hazard to the user.
  316. ↑ Douglas CE, Henson R, Drope J, Wender RC (July 2018). "The American Cancer Society public health statement on eliminating combustible tobacco use in the United States". CA. 68 (4): 240–245. doi:10.3322/caac.21455. PMID 29889305. S2CID 47016482. It is the smoke from combustible tobacco products—not nicotine—that injures and kills millions of smokers.
  317. ↑ Dinakar C, O'Connor GT (October 2016). "The Health Effects of Electronic Cigarettes". The New England Journal of Medicine. 375 (14): 1372–1381. doi:10.1056/NEJMra1502466. PMID 27705269. Beyond its addictive properties, short-term or long-term exposure to nicotine in adults has not been established as dangerous
  318. ↑ Schraufnagel DE (March 2015). "Electronic Cigarettes: Vulnerability of Youth". Pediatric Allergy, Immunology, and Pulmonology. 28 (1): 2–6. doi:10.1089/ped.2015.0490. PMC 4359356. PMID 25830075.
  319. ↑ England LJ, Bunnell RE, Pechacek TF, Tong VT, McAfee TA (August 2015). "Nicotine and the Developing Human: A Neglected Element in the Electronic Cigarette Debate". American Journal of Preventive Medicine. 49 (2): 286–293. doi:10.1016/j.amepre.2015.01.015. PMC 4594223. PMID 25794473.
  320. ↑ Marsot A, Simon N (March 2016). "Nicotine and Cotinine Levels With Electronic Cigarette: A Review". International Journal of Toxicology. 35 (2): 179–185. doi:10.1177/1091581815618935. PMID 26681385. S2CID 12969599.
  321. ↑ England LJ, Aagaard K, Bloch M, Conway K, Cosgrove K, Grana R, et al. (January 2017). "Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products". Neuroscience and Biobehavioral Reviews. 72: 176–189. doi:10.1016/j.neubiorev.2016.11.013. PMC 5965681. PMID 27890689.
  322. 1 2 Offermann F (June 2014). "The Hazards of E-Cigarettes". ASHRAE Journal. 56 (6).[permanent dead link]
  323. 1 2 Bourke L, Bauld L, Bullen C, Cumberbatch M, Giovannucci E, Islami F, et al. (June 2017). "E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks". European Urology. 71 (6): 915–923. doi:10.1016/j.eururo.2016.12.022. hdl:1893/24937. PMID 28073600.
  324. ↑ Born H, Persky M, Kraus DH, Peng R, Amin MR, Branski RC (July 2015). "Electronic Cigarettes: A Primer for Clinicians". Otolaryngology–Head and Neck Surgery. 153 (1): 5–14. doi:10.1177/0194599815585752. PMID 26002957. S2CID 10199442.
  325. ↑ Kaur G, Pinkston R, Mclemore B, Dorsey WC, Batra S (March 2018). "Immunological and toxicological risk assessment of e-cigarettes". European Respiratory Review. 27 (147): 170119. doi:10.1183/16000617.0119-2017. PMC 9489161. PMID 29491036.
  326. ↑ Jia-You G, Ghosh M, Hoet P (October 2023). "Association between metal exposure from e-cigarette components and toxicity endpoints: A literature review". Regulatory Toxicology and Pharmacology. 144 (105488) 105488. doi:10.1016/j.yrtph.2023.105488. PMID 37657743.
  327. ↑ Nowak D, Jörres RA, Rüther T (May 2014). "E-cigarettes--prevention, pulmonary health, and addiction". Deutsches Ärzteblatt International. 111 (20): 349–355. doi:10.3238/arztebl.2014.0349. PMC 4047602. PMID 24882626.
  328. ↑ Schroeder MJ, Hoffman AC (May 2014). "Electronic cigarettes and nicotine clinical pharmacology". Tobacco Control. 23 (Supplement 2): ii30–ii35. doi:10.1136/tobaccocontrol-2013-051469. PMC 3995273. PMID 24732160.
  329. ↑ Benowitz NL, Burbank AD (August 2016). "Cardiovascular toxicity of nicotine: Implications for electronic cigarette use". Trends in Cardiovascular Medicine. 26 (6): 515–523. doi:10.1016/j.tcm.2016.03.001. PMC 4958544. PMID 27079891.
  330. ↑ Drope J, Cahn Z, Kennedy R, Liber AC, Stoklosa M, Henson R, et al. (November 2017). "Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine". CA. 67 (6): 449–471. doi:10.3322/caac.21413. PMID 28961314.
  331. ↑ Di Matteo V, Pierucci M, Di Giovanni G, Benigno A, Esposito E (2007). "The neurobiological bases for the pharmacotherapy of nicotine addiction". Current Pharmaceutical Design. 13 (12): 1269–1284. doi:10.2174/138161207780618920. PMID 17504235.
  332. 1 2 3 4 5 6 "Electronic Cigarettes (E-cigarettes)". National Institute on Drug Abuse. March 2018.Public Domain This article incorporates text from this source, which is in the public domain.
  333. ↑ CDC (20 May 2024). "E-Cigarettes and Pregnancy". Maternal Infant Health. Retrieved 31 July 2024.
  334. 1 2 "E-cigarettes (Vaping)", Mother To Baby | Fact Sheets, Brentwood (TN): Organization of Teratology Information Specialists (OTIS), July 2023, PMID 35951787, retrieved 30 July 2024
  335. ↑ Hajek P, Przulj D, Pesola F, Griffiths C, Walton R, McRobbie H, et al. (May 2022). "Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial". Nature Medicine. 28 (5): 958–964. doi:10.1038/s41591-022-01808-0. ISSN 1546-170X. PMC 9117131. PMID 35577966.
  336. ↑ "Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions". U.S. Preventative Services Task Force. 19 January 2021. Retrieved 31 July 2024.